Exploring the dynamics of A-to-I editing in the mammalian brain by O'Neil, Richard Thomas
Exploring the dynamics of A-to-I editing in the mammalian brain 
By 
Richard Thomas O’Neil 
 
Dissertation 
Submitted to the Faculty of the  
Graduate School of Vanderbilt University 
in partial fulfillment of the requirements  
for the degree of  
DOCTOR OF PHILOSOPHY 
in 
Neuroscience 
December, 2015 
Nashville, Tennessee 
 
Approved: 
 
Ronald B. Emeson Ph. D  
 
Karoly Mirnics M.D., Ph.D  
 
Gregg D. Stanwood Ph.D 
 
Roger D. Cone Ph.D 
 
 
 
 
 
 
i 
 
TABLE OF CONTENTS 
LIST OF TABLES………………………………………………………………………………vi 
LIST OF FIGURES……………………………………………………………………………..vii 
LIST OF ABBREVIATIONS……………………………………………………………………ix 
Chapter 
I. INTRODUCTION 
Beyond the central dogma………………………………………………………...1 
Generating functional diversity by RNA editing…………………………………3 
Overview of the 2C-Subtype of 5HT receptor……………………………………8 
 5HT2C receptor molecular biology………………………………………..8 
 Physiological roles for 5HT2C receptors…………………………………12 
 5HT2C receptors regulate metabolism and feeding behavior…………….13 
 5HT2C receptors regulate mesolimbic dopamine signaling………………14 
            Measuring RNA editing of 5HT2C transcripts....………..……………….17 
 
II. INVESTIGATING THE DYNAMICS OF 5HT2C EDITING IN MICE 
Introduction……………………………………………………..………………..22 
Materials and methods…………………………………………………………...23 
RNA extraction………….……………………………………………….23 
  High-throughput multiplexed transcript analysis…….………………….23 
Quantitative Real-time PCR……………………………………………...25 
 Drug Treatment…………………………………………………..………25 
 Stress protocols………….……………………………………………….26 
 Dissections……………….………………………………………………27 
Results……………………………………………………………………………29 
 Measuring RNA editing using HTMTA…………………………………29 
Amplification bias……………………………………………….30 
   Error rate…………………………………………………………30 
                                                Establishing base line 5HT2C editing profiles …….……………..32 
    Reproducibility and inter-animal variability……………………..32 
    Editing in inbred mice……………………………………………34 
    Editing profiles in various mouse brain regions…………………36 
   Editing in animals with manipulated 5HT systems……………………...37 
    Measuring editing after genetic manipulation of 5HT...................37 
ii 
 
    Measuring editing after pharmacologic depletion of 5HT……….41 
    5HT2C editing after exposure to psychiatric medications….…….43 
   Effects of stress on 5HT2C editing profile………………………………45 
    Restraint stress time course study………………………………..46 
    Strain specificity of stress effects………………………………..47  
    Restraint stress effects on editing in adrenalectomized mice……51 
    Effect of 5HT neuronal loss on stress induced editing dynamics..52 
    Effect of maternal separation on 5HT2C editing profile….……...52 
    Monitoring choroid plexus contamination………………………52 
  Discussion……………………………………………………………………….57 
 
III. CHARACTERIZING 5HT2C EXPRESSION IN PRADER-WILLI SYNDROME 
Introduction……………………………................................................................57 
Materials and methods…………….……………………………………………..63 
 Human Tissue Sample Preparation………………………………………63 
 Genotyping to confirm PWS Diagnosis...………………………………..63 
 RNA Characterization…………………….……………………………...63 
 Receptor binding……………….………………………………………...65 
 Genotyping to confirm PWS diagnosis…….…………………………….63 
 Tissue quality control…………………….………………………………66 
Results……………………………………………………………………………67 
                          Analysis of Genotype and Sample Integrity…………………………….67 
   RNA expression and splicing………………………………….…………72
   Analysis of RNA editing…………………………………………………77 
   5HT2C receptor density….……………………………………………….81 
   Analysis of 2’O-methylation…………………………………….……….81
   Discussion………………………………………………………………..86 
  
IV. COMPARATIVE ANALYSIS OF A-TO-I EDITING IN HUMAN AND NON-       
HUMAN PRIMATE BRAINS 
 
Introduction………………………………………………………………………88 
Materials and methods…………………………………………………………...90 
 Editing analysis…………………………………………………………..90 
 Informatics……………………………………………………………….90 
 Statistics………………………………………………………………….91 
 Measuring ADAR mRNA expression…………………………………...91 
Results……………………………………………………………………………92 
 Covariant analysis: CADPS, GluR2, GluR4, GABRA3, mGluR4………92 
Differential regulation of A-to-I editing in different substrates………….92 
 Overall patterns of editing in the brain…………………………………..95 
 Co-regulation of RNA editing…………………………………………...97 
 Global regulation of editing across brain regions……………..………..103 
 Analyzing RNA editing in rhesus macaque…………………………….105 
ADAR expression and editing profiles…………..……………………..106 
iii 
 
  Discussion………………………………………………………………………108 
V. CONCLUSIONS 
 
Editing patterns in the human brain………………………………………………..110 
     5HT2C editing in the human brain……………………………………………….113 
    GABRA3 editing patterns in the human brain….……………….………………114 
    GluR4 editing in the human brain……………………………….………………114 
     mGluR4 editing in the human brain……………………………….…………….115 
    CADPS editing in the human brain………………………………..…………….115 
    GluR2 editing in the human brain…………………………………..……………116 
Editing deficiency in three patients………………………………………………116 
Conclusions………………………………………………………………………117 
CITATIONS……………………………………………………………………………………118 
 
 
 
 
 
 
 
 
 
 
 
iv 
 
LIST OF TABLES 
Table 
1. Summary of A-to-I editing sites in mammals…………….………………………………6 
2. Determining error rate for HTMTA……………………………………………………...32 
3. Summary of samples used in PWS studies………………………………………………67 
 
 
 
 
 
 
 
 
 
 
 
 
 
v 
 
LIST OF FIGURES 
Figure 
1. RNA processing of 5HT2C transcripts……………………………………………………10 
2. Method for measuring editing profile using massively parallel sequencing…………….28 
3. Determining linear range of PCR………………………………………………………..31 
4. Comparison of RNA editing patterns using HTMTA and pyrosequencing……………..34 
5. Analysis of 5HT2C mRNA profiles of different mouse strains…………………………..36 
6. Analysis of brain region-specific 5HT2C RNA editing profiles……………………….....37 
7. Whole brain editing profiles from animals with genetically modified 5HT systems……40 
8. 5HT2C transcript editing after 5HT depletion……………………………………………42 
9. Effect of 28 day saline injection on hippocampus editing….……………………………44 
10. Effect of restraint stress on brain 5HT2C editing profile…………………………………47 
11. Dynamics of recovery from stress effects on 5HT2C editing profile…….………………48 
12. Further efforts to explore effects of restraint stress on 5HT2C editing…………………..51 
13. Effects of early life stress on 5HT2C editing profile……………………………………..53 
14. Expression of the choroid plexus marker F5 in hippocampal tissue…………………….56 
15. Schematic summary of the Prader-Willi Syndrome (PWS) locus……………………….61 
16. Linear regression analysis comparing F5 to 5HT2C expression in hippocampus………..70 
17. Alternative splicing of 5HT2C transcripts…………………..……………………………73 
18. Quantitative analysis of relative 5HT2C mRNA expression…………...………………...74 
19. Quantitative analysis of relative expression for alternative 5HT2C splice variants…...…75 
20. Quantitative analysis of site-selective 5HT2C editing observed in cortex and striatum...76 
 
vi 
 
21. Sequence analysis of brain region-specific 5HT2C RNA  
editing profiles…….………………………………………………….…………………..78 
 
 
22. Comparisons of the most common 5HT2C protein isoforms predicted by the RNA  
editing profile…...…………….…………….……………………………………………77 
23. Quantitative analysis of 5HT2C-specific binding..……………….………………………81 
24. Analysis of site-selective 2’-O-methylation in 5HT2C transcripts ………………………84 
25. Quantitative analysis of editing efficiency for ADAR targets in samples isolated  
from the striatum, cortex, and hippocampus of humans and macaques...…….…...…….94 
26. Quantitative analysis of region-specific site-selective RNA editing patterns ……..……96 
27. Co-regulation of 5HT2C editing across human brain regions………………………..…..98 
28. Co-regulation of multiple substrates across human brain regions…………………….…99 
29. Co-regulation of 5HT2C editing across monkey brain regions………………………….100 
30. Co-regulation of multiple substrates across monkey brain regions…………………….101 
31. Pair-wise correlational analysis of editing patterns for multiple ADAR  
substrates in human cortex…...………………………………………………………... 104 
32. Region-specific ADAR1 and ADAR2 expression in human and rhesus  
macaque brain ………………………………………………………………………….107 
 
 
 
 
 
 
vii 
 
LIST OF ACRONYMS AND ABREVIATIONS 
3H : tritium 
5HT : serotonin 
5HT2C : serotonin 2C receptor 
ADAR : adenosine deaminase acting on RNA 
Adx : adrenalectomized 
Ala : Alanine 
Alu : Alu-type genomic element 
aMSH : alpha-melanocyte stimulating hormone 
ANCOVA : analysis of covariance 
ANOVA : analysis of variance 
Arc : arcuate nucleus of the hypothalamus 
A-to-I editing : adenosine-to-inosine RNA editing 
BAT : brown adipose tissue 
C57Bl/6 : c57 black 6 strain of mice 
CADPS : Calcium activated protein for secretion 
cDNA : complementary DNA 
CP : choroid plexus 
CSF : cerebral spinal fluid 
Ctx : cortex 
DA : dopamine 
∆∆CT : delta-delta cycle threshold  
DNA: deoxyribonucleic Acid 
viii 
 
dsRNA : double-stranded ribonucleic acid 
ECS : editing site complimentary sequence  
ERK : Extracellular signal-related kinase 
Exo I : exonuclease I 
F5 : clotting factor 5 
FLNA : Filamin A 
FLNB : Filamin B 
GABRA3 : Gamma-amino butyric acid receptor α-subunit 3 
GIRK : G-protein coupled inwardly rectifying K+ channel 
Gli1 : Gioblastoma family zinc finger transcription factor 
GluR-2 : AMPA-subtype glutamate receptor subunit 2  
GluR-3 : AMPA-subtype glutamate receptor subunit 3 
GluR-4 : AMPA-subtype glutamate receptor subunit 4 
GluR-5 : Kainate-subtype glutamate receptor subunit 5 
GluR-6 : Kainate-subtype glutamate receptor subunit 6 
Gly : glycine 
GPCR : G-protein coupled receptor 
HBII-52 : Human brain specific snoRNA 52 (SNORD115) 
HBII-85 : Human brain specific snoRNA 85 (SNORD116) 
HCl : hydrochloric acid 
Hip : hippocampus 
HPA : hypothalamic-pituitary-adrenal axis 
HPLC : high-performance liquid chromatography 
ix 
 
HTMTA : high-throughput multiplex transcript analysis 
IC : imprinting center 
INI : isoleucine-asparagine-isoleucine isoform of the 5HT2C receptor 
Kv1.1 : voltage- gated potassium channel 1.1 
MBII-52 : mouse brain specific snoRNA 52 
MBII-85 : mouse brain specific snoRNA 85 
mGluR4 : metabatropic glutamate receptor 4 
mRNA : messenger RNA 
NAc : nucleus accumbens 
OB : olfactory bulb 
P#: postnatal day 
pCPA : parachlorophenylalanine 
PCR : polymerase chain reaction 
Pet1 : gene encoding the Fev transcription factor 
PLA2 : Phospholipase A2 
PMI : postmortem interval 
POMC : pro-opiomelanocortin 
PWS : Prader-Willi Syndrome 
RNA : ribonucleic Acid  
rRNA : ribosomal RNA 
RT-PCR : reverse transcriptase polymerase chain reaction 
SBB : standard binding buffer 
SEM : standard error of the mean 
x 
 
SERT : serotonin transporter 
SNORD : gene encoding a small nucleolar RNA 
snoRNA : small nucleolar ribonucleic acid 
snRNA : small nuclear RNA 
SSRI : selective serotonin reuptake inhibitor  
Str : striatum 
TH : tryptophan hydroxylase 
tRNA : transfer RNA 
VGV : valine-glutamic acid-valine isoform of the 5HT2C receptor 
VSV : valine-serine-valine isoform of the 5HT2C receptor 
VTA : ventral tegmental area 
WB : whole brain 
 
xi 
 
 Chapter I 
INTRODUCTION 
Beyond the central dogma 
Life successfully evolved on earth because nucleic acids have formed a template for 
high-fidelity transfer of biological information through time in the form of genomes. The discrete 
components harboring information in the genome are genes and this information is coded in a 
sequential arrangement of covalently bound nucleic acids; the genome sequence. The genome 
sequence fundamentally dictates how an organism grows, reproduces, and interacts with the 
universe. Francis Crick first proposed the information flow used by peptide coding genes, a 
process he referred to as the “central dogma of molecular biology” [1]. In summary, it states that 
the deoxyribonucleic acid (DNA) polynucleotide sequence serves as a template for the synthesis 
of ribonucleic acid (RNA) polynucleotides. These RNAs then serve as templates for polypeptide 
synthesis, whereby the sequential incorporation of amino acids in the peptide is dictated by the 
RNA sequence. The “dogma” provides a useful framework for thinking about the transduction of 
genetic information, but should not diminish the importance of parallel processes that impart an 
even greater capacity to encode information in the genomic context. Interactions between 
proteins and nucleic acids have permitted the emergence of complex and dynamic systems that 
are conserved and selected by evolution generating a vast diversity of protein coding potential. 
The goal of the work described here is to better understand one such mechanism, known as 
adenosine-to-inosine RNA editing (A-to-I editing). 
 Organisms interact with the environment using a diverse milieu of physiological 
responses often involving changes in gene expression. The staggering variety of cellular 
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 functions needed to support adaptive responses led early genomic researchers to hypothesize that 
the genomes of complex organisms like humans must harbor millions of protein coding genes. 
However, as progress was made in mapping, sequencing, and annotating the genomes of many 
organisms biologists were faced with the realization that the number of protein coding genes in 
multicellular organisms is typically on the order of thousands, not millions [2]. This insight 
yielded a new appreciation for mechanisms that generate molecular diversity from a finite 
genome. The need to conserve precious genomic information makes genome modification an 
unfavorable mechanism for generating functional diversity. Conversely, RNA is transiently 
expressed and represents a viable template for active molecular diversification; leaving the 
precious genome intact. Several mechanisms for generating protein diversity by RNA 
modification such as alternative splicing and RNA editing have been identified.  
In most eukaryotic organisms, RNAs generated during transcription of genomic DNA do 
not typically encode a polypeptide in a single contiguous segment. Instead, these primary 
transcripts known as pre-messenger RNAs (pre-mRNAs) contain sequences encoding parts of a 
polypeptide interspersed within long regions of non-coding intervening sequences called introns. 
The individual units of regulatory and peptide-coding RNA between the introns are referred to as 
exons. During a process known as splicing, introns are removed and exons are joined together to 
form mature, peptide-coding messenger RNAs (mRNAs) [3]. The number of exons contained in 
a gene varies widely from a single exon to several hundred exons. Differential inclusion of these 
exons, known as alternative splicing, generates a diversity of mRNAs encoding peptides with 
unique primary structures all encoded by a single gene [4]. Generating protein diversity from a 
limited genome is invaluable for complex organisms; as such, a variety of mechanisms in 
addition to alternative splicing, like RNA editing, also have evolved for this purpose.   
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 Generating of functional diversity by RNA editing 
RNA editing refers to a number of post-transcriptional modification processes which alter 
the sequence of RNAs such that they differ from that of the genomic template from which they 
are derived. Several types of RNA editing have been described including insertion, excision, or 
covalent modification of nucleotides [5]. Editing can have a range of effects on RNA function 
including creation of new structural characteristics, modulation of RNA stability, or microRNA 
target selection [6, 7]. In the context of mRNAs, editing also can lead to the introduction of new 
stop codons or open reading frames, modulation of splice-site selection [8], or amino acid 
substitutions [9]. The work presented here is focused upon characterization of a particular form 
of RNA editing referred to as adenosine-to-inosine (A-to-I) editing. This RNA modification 
involves hydrolytic deamination of specific adenosine moieties at the C6 position; thereby 
converting adenosines to inosines [10]. A-to-I editing has been conserved throughout metazoan 
evolution where it is observed in species ranging from nematodes and insects, to fish and 
mammals [7].   
There are a variety of potential effects of replacing an adenosine with inosine stemming 
from the fact that inosine forms a stable I-C base-pair with the same geometry as guanosine, 
albeit with one fewer hydrogen bond per pair. It is for this reason that inosine appears to function 
like guanosine in RNA [11]. Edited nucleotides can be detected indirectly by sequencing 
complementary DNA (cDNA); reverse transcriptase incorporates cytosine in the complementary 
strand for template inosine moieties during cDNA polymerization leading to disparity in the 
sequence of cDNA from that of genomic DNA [12]. The identification of these A-to-G 
discrepancies in cDNA libraries facilitated the discovery of hundreds of A-to-I editing events in 
many animal species. In addition to altering base incorporation during reverse transcription, 
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 inosine contained in mRNA open reading frames base pair with cytosine in the anticodon loop of 
tRNAs which can alter the amino acid sequence of the peptide encoded by edited mRNAs [13]. 
The non-synonymous amino acid substitutions resulting from editing within codons can lead to 
profound functional changes for the encoded protein product. Several A-to-I editing events that 
predict changes in amino acid codons have been identified in a variety of animals, many of 
which are highly conserved in mammals.  
 The extensive conservation of specific sites selected for codon editing as well as 
anatomic editing profiles observed in different mammalian species is striking. The extensive 
conservation of such events suggests that the particular amino acids which are altered by editing 
have an important role in the encoded peptide’s function. It also implies that the ability to edit 
these sites confers an advantage that has been maintained by evolution. Indeed, numerous studies 
have identified profound changes in protein function affecting overall physiology when only a 
single amino acid changes as a result of A-to-I editing [14]. For this reason, it is of paramount 
importance to identify the functional role of editing within different mRNA substrates as well as 
the dynamic processes that regulate A-to-I conversion in both healthy and in pathological states.  
A-to-I editing is catalyzed by a group of enzymes known as adenosine deaminases that 
act on RNA or ADARs. These ADAR proteins facilitate hydrolytic deamination at carbon-6 of 
adenosines with the oxygen in a water molecule serving as the nucleophile. The ADAR enzymes 
seem to require that the edited ribonucleotides lie within an extended intermolecular duplex and 
interact with RNA via conserved double stranded RNA binding motifs which are characteristic 
of all ADAR enzymes [7].  However, more research is required to determine how precise 
targeting of deamination events to particular adenosines within such duplexes is directed. 
Through extensive homology searches, three highly-related proteins of the ADAR family have 
4 
 
 been identified in mammals. These proteins are referred to as ADAR1, ADAR2, and ADAR3. 
All three mammalian ADAR proteins have similar double-stranded RNA binding motifs 
presumed to facilitate targeting to double-stranded RNA regions, and in the case of ADAR1 and 
ADAR2, a conserved deaminase domain [7]. For ADAR3, there is no evidence of catalytic 
activity, suggesting that ADAR3 might play an alternative or supporting role in RNA processing 
[15]. While ADAR1 and ADAR2 display some overlapping substrate specificity, they also target 
unique adenosines within specific RNA substrates [16].      
A-to-I editing is particularly interesting within the context of neuroscience for several 
reasons. The enrichment of inosine containing transcripts in the CNS, particularly in the primate, 
has been hypothesized to be a driving force in the evolution of the human brain [17]. ADAR 
proteins are enriched in neural tissues, particularly in neurons within the CNS, and many of the 
mRNAs that have been identified as substrates for A-to-I editing encode proteins which are 
important for nervous system function [7, 17]. These include voltage-gated [18] and ligand-gated 
ion channels [19], components of synaptic release machinery, regulatory proteins [20, 21], and at 
least two metabotropic neurotransmitter receptors [9, 22]. Table 1 contains a table summarizing 
many of the A-to-I editing events that have been identified in mammals. 
By gaining a better understanding of the biological significance of codon-changing RNA editing 
events, new insights have been revealed about the key roles played by these proteins in 
fundamental neuronal processes. Unfortunately, determining the functional relevance of mRNA 
editing events that produce non-synonymous amino acid substitutions is limited by the functional 
assays available for interrogating protein function. The effect of such amino acid substitutions is 
typically studied by expressing cDNAs harboring either a guanosine or adenosine at the editing 
site under interrogation in an appropriate model system.  
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 The best characterized RNA editing effects have generally involved ion channels because 
nuanced studies of their biophysical properties are permitted by various electrophysiological 
recording techniques. A seminal study with edited GluR-2 subunits of the AMPA-subtype of 
ionotropic glutamate receptor revealed that an A-to-I editing event leading to the substitution of 
glutamine with an arginine in the predicted ion pore conferred impermeability to calcium ions 
[12]. This change has profound ramifications for the effects of channel activation because 
calcium ions are highly regulated signaling molecules in neuronal cells. This observation 
fostered the remarkable realization that proteins harbor conserved switches that are actually 
exploited by RNA editing to confer dynamic functionality.    
 The first studies of editing in vivo were made possible by the development of gene-
targeting techniques in mice. Initially, mice were generated harboring null mutations in each 
respective ADAR gene. In these studies it was observed that ADAR1-null homozygotes die at 
embryonic day 11.5 (E11.5), while ADAR2-null animals suffer from seizures and die between 3 
and 5 weeks of age [16, 23]. These results indicated that RNA editing is indispensable for normal 
murine development and physiology, but initially failed to foster many useful insights about the 
particular role of different edited substrates. To determine the role played by editing at specific 
substrates, gene-targeting has been used to generate mice harboring a guanosine in the genome at 
the edited position to mimic the edited inosine containing transcript. To complement these 
studies it has also been useful to generate mice that express only the non-edited form of the 
transcript. This is generally achieved by disrupting the obligate duplex structure required for 
ADAR-mediated deamination without introducing nonsense or missense mutations into the gene. 
To date, mutant mice have been generated which exclusively express either the non-edited or 
edited isoforms of the GluR-2 subunit, the 5HT2C [24], and the voltage gated potassium channel 
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 subunit, Kv1.1, respectively. Interestingly, the neonatal lethality of the ADAR2-null phenotype 
could be rescued by co-expression of an edited GluR-2 (R) allele, indicating that the primary 
reason for lethality was an inability to edit GluR-2 transcripts [15,22]. As such, detailed 
phenotypic characterization of mutant mice bearing a non-edited GluR-2 allele was precluded by 
an early lethality similar to that observed in ADAR2-null animals. The lethality observed for 
both lines of mutant mice is presumed to result from the role this editing event plays in 
regulating calcium permeability[16]. Mutant mice solely expressing either the edited or non-
edited isoforms of the 5HT2C receptor [24, 25] or Kv1.1 transcripts reach adulthood and 
phenotypic characterization is ongoing. The primary goal of the work described here is to further 
address questions related to the functional significance and the dynamic regulation of RNA 
editing for 5HT2C receptor transcripts. 
Overview of the 2C-Subtype of 5HT Receptor 
5HT2C receptor molecular biology 
The 5HT2C transcript represents an interesting substrate for studying the mechanisms 
regulating A-to-I editing, because it contains five editing sites in close relative proximity which 
are all located in a single duplex structure [9]. Despite the proximity of these five editing sites 
(referred to as sites A, B, E, C, and D respectively) they display differential susceptibility to 
deamination by ADAR1 and ADAR2 [16, 23]. Furthermore, different combinations of editing at 
these five sites can generate up to 32 RNA isoforms which can encode up to 24 unique protein 
isoforms differing by three amino acids predicted to lie in the second intracellular loop of the 
mature receptor protein. Comprehensive analysis of the functional differences between the 24 
possible 5HT2C isoforms has not been performed to date, but extensive analysis of some of the 
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 most commonly expressed isoforms has yielded some useful information about the functional 
consequences of editing for 5HT2C mRNAs.  
5HT2C receptors are members of the A class of G-protein coupled receptors (GPCRs) 
encoded on the X-chromosome in mammals [26, 27]. The gene contains 6 exons and at least 
three isoforms are generated as a result of alternative splicing, only one of which is predicted to 
encode a functional GPCR [28]. As noted previously, even greater functional diversity is 
conferred to the 5HT2C locus by five conserved A-to-I editing events that have been identified in 
exon 5 [29]. The genomically-encoded 5HT2C receptor transcript predicts isoleucine, asparagine 
and isoleucine at amino acid positions 156, 158 and 160, respectively (coordinates relative to the 
initiator methionine in the human peptide sequence). In the case of 5HT2C, the protein isoforms 
resulting from differentially edited RNAs are generally referred to by the identity of amino acids 
encoded at these three positions, such that the non-edited RNA encodes the INI isoform. 
Likewise, a receptor encoded by an RNA harboring inosine (or guanosine) at each of these five 
sites encodes valine, glycine, and valine (VGV) at the analogous positions [30]. The best 
characterized functional differences between different edited isoforms of the 5HT2C receptor are 
related to signaling activity [29]. The primary G-proteins activated by 5HT2C receptors are 
thought to be those of the Gαq/11 class which directly stimulate phospholipase C (PLC) [31]. 
While PLC activation is the most commonly used readout of 5HT2C activity in heterologous 
systems, several studies provide evidence for potent efficacy on other effector  
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 Figure 1. RNA processing of 5HT2C transcripts. A) The conserved genomic organization of 
the mammalian HTR2C gene located on Xq24. Relative size and locations of exons are 
indicated with boxes. The green arrow indicates the translation start site and red arrows indicate 
the locations of five A-to-I editing sites. The black arrows at the exon-intron junction of exon 5 
indicate the location of nucleotides that forms the predicted hairpin duplex recognized by 
ADAR enzymes. Three different isoforms generated by alternative splicing have been reported. 
RNA2 encodes the functional 5HT2C receptor. B) A schematic diagram showing the predicted 
topology of the 5HT2C receptor. The predicted positions of the amino acid residues altered by 
editing are indicated by blue circles. The genomically encoded amino acids at these three 
positions are indicated in yellow. The genomic sequence of the edited region is shown with the 
substrate adenosines indicated in red and the names of the respective sites are indicated in 
green. Amino acid encoded after editing at each site or combination of sites is indicated. 
10 
 
 pathways [32]. Importantly, 5HT2C receptors activate GIRK channels in vivo [33] and 
phospholipase A2 (PLA2) via heterotrimeric G-protein-dependent mechanisms [34]. In addition, 
5HT2C receptors also appear to activate extracellular signal related kinase (ERK1 and ERK2) 
cascades through a G-protein independent, β-arrestin-dependent pathway [35].  
Initial efforts to investigate the functional role of 5HT2C editing were focused on 
elucidating the pharmacological properties of receptors encoded by different combinations of 
editing. The amino acids altered by editing are predicted to reside in the second intracellular loop 
of the receptor only a few residues away from the conserved DRY motif; a ‘microswitch’ 
thought to be important for G-protein activation [36]. The properties of the different edited 
isoforms of the 5HT2C receptor were initially studied by comparing 5HT-stimulated 
phosphoinositide hydrolysis in cells expressing cDNAs encoding either the VSV or INI receptor 
isoforms. Efficient 5HT-stimulated PLC activation was observed in both cases, indicating that 
both isoforms couple similarly to parallel transduction pathways. However, the EC50 value for 
cells expressing the INI isoform indicated that the potency of 5HT to stimulated PLC activity is 
approximately 15-fold greater than cells expressing the VSV isoform, despite similar affinities 
for orthosteric ligands [9]. This finding attracted the attention of a number of GPCR 
pharmacologists who have contributed to characterization of the biophysical consequences of 
RNA editing for this receptor [27]. While these studies continue to provide additional insights 
about 5HT2C signaling, the core finding with the greatest biological relevance is that agonist-
independent (constitutive) activity is high for the INI isoform and essentially undetectable for the 
fully-edited (VGV) isoform of the receptor. The other edited isoforms have not been studied in 
detail, but they appear to display intermediate levels of constitutive activity that fall between that 
of INI and VGV. A similar rank order of potency is observed for the G-protein-dependent 
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 activation of phospholipase A2 [37]. Interestingly, this generalization also seems to apply to the 
receptor’s behavior in G-protein independent processes primarily thought to result from β-
arrestin and calmodulin interactions [35, 38].  
GPCRs are subjected to dynamic trafficking and inhibition as a response to agonist 
stimulation. This process is thought to be regulated primarily by direct interactions between 
GPCRs and cytoplasmic proteins known as β-arrestins. β-arrestins are recruited to active GPCRs 
where they block association with heterotrimeric G-proteins. In addition to physically blocking 
the G-protein binding site, GPCR-associated β-arrestins promote the formation of endocytotic 
vesicles which facilitate internalization of the GPCR [39]. In heterologous systems, INI receptors 
appear to have an increased tendency to be internalized into an endosomal compartment 
compared to VSV receptors, and VGV receptors largely appear to accumulate on the cell surface. 
These findings mirror the effects of editing observed for G-protein-dependent signaling 
pathways. In the case of the 5HT2C receptor, β-arrestin binding not only facilitates 
internalization, but also stimulates ERK1/2 phosphorylation in what appears to a calmodulin-
dependent process[35, 38]. This ERK1/2 phosphorylation elicits changes in gene expression that 
affect cell physiology depending on biological context. Taken together, it appears that a primary 
role of RNA editing at 5HT2C receptor transcripts is to tune the constitutive activity of receptors 
to meet physiological needs.  
Physiological roles of 5HT2C receptors 
5HT2C receptors are expressed throughout the central nervous system and mRNA can be 
detected in many parts of the brain with highest levels of expression observed in the ependymal 
tissue lining the ventricles known as choroid plexus [40] [41]. Studies in rodents also confirm an 
important roles for 5HT2C receptors in the arcuate nucleus of the hypothalamus in the regulation 
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 of feeding behavior and metabolism [42, 43]. Several lines of work have also indicated that 
5HT2C receptors expressed in the midbrain regulate dopamine (DA) release in the limbic 
forebrain modulating goal-directed behavior [44]. 5HT-based drug intervention is at the forefront 
of the struggle to treat a wide array of psychiatric and metabolic disorders including 
schizophrenia, depression, anxiety, addiction, and obesity and 5HT2C receptors have established 
roles in the transduction of 5HT signals relevant to these disease processes [45].  
5HT2C receptors regulate metabolism and feeding behavior  
 Regulating metabolism and feeding behavior is one of the most ubiquitous and 
fundamental functions facilitated by the mammalian nervous system. The brain maintains 
metabolic homeostasis through regulation of physical activity, autonomic tone, glucose 
homeostasis, and by providing the motivational drive to consume food. The notion that 5HT 
directly regulates feeding behavior dates back to initial studies indicating that it was a satiety 
hormone [46]. A concept exploited by the pharmaceutical industry beginning in the late 1960’s 
when the drug fenfluramine came on the market for weight loss. The anorexigenic effects of 
fenfluramine have been attributed to its ability to increase extracellular 5HT levels [47]. Studies 
in which knockout mice lacking 5HT2C receptors are treated with fenfluramine provided strong 
evidence that the 5HT2C receptor plays a primary role in mediating the inhibition of feeding. The 
anorexigenic efficacy of fenfluramine was greatly attenuated in these 5HT2C-null animals, 
whereas untreated knockout-mice are hyperphagic and developed adult onset obesity [48] [49]. 
More recently, electrophysiological and molecular techniques have allowed for a more precise 
characterization of the receptor’s role in feeding. In mice, pro-opiomelanocortin (POMC) 
neurons located within the arcuate nucleus (Arc) of the hypothalamus express the 5HT2C receptor 
and that receptor activation promotes excitability and increased release of α-melanocyte 
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 stimulating hormone (αMSH) [50]. Accumulating evidence implicating the 5HT2C receptor as a 
key component in the regulation of feeding behavior has made it an attractive target for new anti-
obesity drugs. The drug Lorcaserin, a selective 5HT2C agonist, was approved for the treatment of 
obesity in 2012 and is currently marketed by Arena Pharmaceuticals.   
Significant metabolic alterations in the animals which only express the VGV receptor 
isoform suggest that the role of this receptor in regulating metabolism is more complicated than 
previously appreciated. These animals display poor feeding in infancy, mirrored with 
hyperphagia, which is offset by elevated brown fat thermogenesis (BAT) in adulthood [25, 51]. 
Consistent with the hypothesis that efficient excitatory drive in POMC neurons, facilitated by 
5HT2C receptor signaling, is required for normal inhibition of feeding, the adult onset 
hyperphagia observed in VGV mice is similar to that observed in the 5HT2C null animals [25]. 
Currently, it is not clear if this hyperphagia is directly related to deficient activation of POMC 
neurons in the Arc, or some indirect feedback mechanism related to the increased basal 
metabolic rate resulting, at least in part, from enhanced BAT. These results provide strong 
evidence that alterations in RNA editing at 5HT2C transcripts can fundamentally disrupt 
metabolic homeostasis in mice.  
5HT2C receptors regulate mesolimbic dopamine signaling  
 Animals possess the unique ability to physically interact with their environment to 
promote their own survival and reproduction. Goal-directed behavior and adaptive learning have 
evolved in vertebrates to facilitate the need to efficiently respond to the nearly infinite possible 
circumstances with which an animal may find itself. Mechanistically, goal-directed behavior and 
adaptive learning requires that an animal can identify a goal, perceive relevant sensory stimuli, 
generate possible motor responses, and anticipate the relative utility of these responses for 
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 attaining the goal. The ability to encode reward upon the execution of effective motor sequences 
allows animals to modify and perfect behavioral sequences to efficiently achieve goals. The 
mesolimbic system, which includes; the nucleus accumbens (NAc), olfactory tubercle, ventral 
pallidum, mediodorsal thalamus, ventral tegmental area (VTA), lateral hypothalamus, limbic 
cortex, and amygdala provides the neural substrate for reward-associated learning and motivated 
behavior [52]. DA release in the NAc and olfactory tubercle is thought to be a key component in 
goal-directed selection of motor programs and in the neural coding of reward. Dopamine is 
supplied to the ventral striatum primarily by groups of neurons located in the midbrain known 
collectively as the VTA, and its release in the medial shell of the NAc and medial olfactory 
tubercle directly correlates with the rewarding effects of achieving goals as well as the 
reinforcing effects of drugs of abuse [53].  
5HT is supplied to the structures of the mesolimbic system by neurons in the dorsal raphe 
and plays a significant role in the regulation of NAc DA release [54]. 5HT2C receptor transcripts 
can be detected by in situ hybridization within the VTA and throughout the NAc [55] and 
autoradiography and immunohistochemistry have confirmed that 5HT2C receptors are expressed 
in these brain areas [56, 57].  Studies in which selective 5HT2C receptor agonists, antagonists, 
and inverse agonists are administered while monitoring DA levels in NAc via microdialysis 
suggest that active 5HT2C receptors have a net inhibitory effect on both baseline and drug-
induced DA release in the ventral striatum. Specifically, intra-accumbal infusion of an inverse 
agonist, but not antagonist, increases basal DA efflux in the NAc. Furthermore, acute decreases 
in basal accumbal DA levels are elicited by systemic infusion of a 5HT2C agonist, and these 
effects can be attenuated by intra VTA infusion of the 2C-selective antagonist SB 242084 [58]. 
These results suggest that phasic activation of 5HT2C receptors in the VTA attenuates DA levels 
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 in the limbic forebrain and that constitutive activity of receptors in the NAc provide tonic 
suppression of DA release. Further supporting an inhibitory role for 5HT2C receptors on DA 
release are the observations that systemic administration of either an inverse agonist or agonist 
results in a dose-dependent increase or decrease in the firing rate of dopaminergic neurons in the 
VTA, respectively [54].  
5HT2C activation is predicted to have excitatory effects on cells expressing the receptor 
leading to the hypothesis that 5HT2C receptors in the NAc and VTA negatively regulate DA 
release by activating inhibitory GABAergic interneurons which, in turn, directly inhibit 
dopaminergic neuron activity. In support of this model, 5HT2C immunoreactivity has been 
observed primarily in GABAergic cell bodies within the VTA and NAc. Recently, several 
studies have attempted to evaluate the effects of various serotonin receptor ligands on the 
acquisition of stimulant addiction and on reinstatement of drug seeking behavior after extinction. 
The inhibitory role of 5HT2C receptor agonists on DA release led to the hypothesis that such 
drugs could be effective in treating addiction. Indeed, several studies have indicated that 
systemic administration of 5HT2C-selective agonists decreases the acute hyperlocomotive 
response to stimulants and reduces self-administration and reinstatement of cocaine seeking 
behavior [59]. All of the subcortical 5HT2C receptor populations analyzed seem to provide a net 
inhibitory drive on NAc DA release, but the differential responses to inverse agonists and 
antagonists, suggests that different populations of receptors play distinct roles in responding to 
5HT. A potential mechanism for these functional differences is the possibility that select cell 
types or nuclei may express different edited isoforms of the 5HT2C receptor, fulfilling the need 
for variable levels of constitutive activity either promoting tonic or phasic control of DA release. 
The important implications of this hypothesis obviate a need to better understand the regulation 
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 of RNA editing at 5HT2C transcripts as well as a detailed analysis of receptor isoform profiles 
expressed in discrete cell types within these brain regions.  
Measuring RNA editing of 5HT2C transcripts 
The 5HT2C transcript is unique among A-to-I editing substrates because it contains 
multiple adenosines in close proximity, some of which are selectively deaminated by only one of 
the two ADAR enzymes. ADAR1 and ADAR2 recognize an extended duplex structure in 5HT2C 
pre-mRNA that forms between the edited region of exon 5 and a complementary region within 
intron 6, referred to as the editing complementary sequence (ECS) [9]. Despite the fact that all 
five sites lie within the same duplex, it appears that intrinsic selectivity exists for which sites are 
deaminated by ADAR1 and ADAR2, respectively [16, 23, 60]. This is remarkable considering 
that the enzymes have a short temporal window to access the editing site before splicing occurs 
and the ECS is removed from the pre-mRNA transcript. The current model is that ADAR1 
efficiently edits the A and B sites and ADAR2 edits the C and D sites. This is based on in vitro 
editing assays where cells are transfected with a 5HT2C minigene and either ADAR1 or ADAR2, 
resulting in selective editing at ADAR1 and ADAR2 sites. Further evidence is derived from the 
observation that in ADAR1 knockout mice, editing at the A and B sites is entirely ablated. 
Interestingly, editing at ADAR2 sites are increased in these animals implying that competition 
for access to the 5HT2C editing site may play an important role in regulating the extent of editing 
[23]. One interpretation of this result is that ADARs bind the duplex in a mutually exclusive 
manner and editing can be regulated by reciprocal competition for access to the substrate duplex. 
This model is further supported by results from experiments that examined editing of 5HT2C 
transcripts in mutant mice with disrupted autoregulation of ADAR2 expression. The ADAR2 
pre-mRNA contains a conserved A-to-I editing site referred to as the -1 site. When this site is 
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 edited it generates a non-canonical splice acceptor that leads to a frame shift resulting in a 
truncated protein lacking dsRNA binding and deaminase activity. This is presumed to serve as a 
negative autoregulatory feedback mechanism limiting the abundance of functional ADAR2-
encoding transcripts. Mutant mice that cannot edit at the -1 site lose ADAR2 autoregulation 
resulting in a subsequent increase in ADAR2 protein. These mice edit more efficiently at the C 
and D sites and edit less efficiently at the A and B sites further supporting the model that 
competition exists between ADAR1 and ADAR2 for access to the editing site duplex[8]. 
Interestingly, transgenic mice which over express the most active form of ADAR2, driven by a 
strong, human cytomegalovirus promoter do not show alterations in editing at any of the five 
5HT2C sites [61]. This could result from insufficient increases in ADAR2 expression to affect the 
competition ratio at the editing site or from a deficiency in some unidentified RNA processing 
event required for appropriate expression and trafficking of the ADAR2 protein that was missing 
from the transgene. As an initial step to better understand the regulation of A-to-I editing in 
5HT2C transcripts, it was necessary to accurately characterize editing profiles at distinct 
developmental time points, in different tissues and in different mouse strains.  
Most approaches for quantifying RNA editing rely on the fact that reverse transcriptase 
recognizes inosine as guanosine, incorporating cytosine in the newly synthesized complementary 
strand. In some cases, reverse transcription of RNA followed by primer extension designed to 
discriminate T from C in the cDNA is useful for accurately measuring the extent of editing in an 
RNA sample. However this approach faces several drawbacks including poor sensitivity for low 
abundance RNAs. Furthermore, it can only interrogate a single site at a time which is not ideal 
for substrates like the 5HT2C transcript which contain multiple editing sites in close proximity to 
one another. These problems obviated the need to develop different approaches for quantifying 
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 5HT2C editing profiles. The initial solution was to amplify the cDNA using PCR primers 
flanking the editing region and ‘shotgun’ subclone the resulting PCR amplicons into plasmids 
before transforming into E. coli. Bacterial clones harboring plasmids containing a single 
amplicon, corresponding to a single edited RNA species could be analyzed subsequently by 
conventional Sanger sequencing. By analyzing a large number of colonies an approximation 
could be made of the relative abundance of different edited isoforms [9]. This approach has the 
advantage of providing information about the combinations of editing that occur in 5HT2C 
transcripts, as well as providing insights into how editing at each site might be related and which 
protein isoforms are encoded. The major problem with this method however, is that a very large 
number of clones must be analyzed to accurately assess the 5HT2C editing profile. Despite this 
limitation, a number of groups proceeded to analyze editing in rodent and human tissues 
generating a variety of hypotheses relating editing at 5HT2C transcripts to altered functions and 
disease states.  
The most compelling early studies were related to tissue-specific patterns of editing in the 
brain. The editing profile in most brain regions appeared to be similar, such that transcripts 
encoding the VNV isoform made up close to 50% of the transcript population in mice while 
those encoding the VSV isoform predominate in human brain. Another universal finding was 
that while 5HT2C receptors are highly expressed in the choroid plexus, editing at ADAR1 sites is 
essentially undetectable, owing to the undetectable levels of ADAR1 in this tissue. Interestingly, 
editing at the ADAR2 sites are not increased suggesting that the extent of ADAR2 editing at 
5HT2C transcripts is not exclusively regulated by competition with ADAR1in all cellular contexts 
[51].  
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 5HT signaling pathways are implicated widely in the etiology of behavioral and 
psychiatric disorders and several 5HT receptors, including the 5HT2C receptor, are thought to be 
important targets for pharmacological intervention. In humans, antipsychotic drugs used in the 
treatment of schizoaffective disorders interact with 5HT2C receptors [62] and the 5HT2C 
transcript is detected in several brain regions thought to be involved in psychiatric impairments 
associated with depression, anxiety disorders, and schizophrenia [40]. For these reasons, several 
groups have examined whether changes in 5HT2C editing profiles are dynamic and could play a 
role psychiatric dysfunction. Initial hypotheses regarding 5HT2C editing suggested that it might 
be altered in various pathological states. This stemmed from reports of altered editing efficiency 
at one or more sites for 5HT2C transcripts isolated from depressed suicide victims [63]. Attempts 
to model these changes in mice also initially showed promise, yet as additional laboratories 
attempted to reproduce the findings of these studies, it became apparent that better tools for 
quantitative analysis of editing profiles would be required. The data provided in early studies 
was likely to be unreliable due to the fact that they were based on the analysis of an inadequate 
number of recombinant cDNA clones[30]. These studies reported editing profiles from inbred 
mouse strains which were inconsistent with those observed by our lab and others [51] as a result 
of statistical undersampling. 
Several reports have provided evidence for alterations in editing within human disease 
cohorts and in rodents exposed to various pharmacologic and behavioral paradigms, however 
these reports have failed to produce consistent results and no reproducible alterations in editing 
have been associated with any particular disease cohort [30]. This is likely due to several factors 
including inconsistency in the precise brain regions analyzed, inherent diversity in human 
populations, and technical limitations that have made it difficult to accurately determine the 
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 profile of edited 5HT2C transcript isoforms in a tissue sample. Recently, advances in sequencing 
technology have made it possible to accurately determine the editing profile for 5HT2C 
transcripts in a tissue sample with unprecedented accuracy and reproducibility [51]. This new 
approach, based on the latest generation of massively parallel sequencing technology, promises 
to renew efforts towards understanding the role of A-to-I editing for numerous RNA species in 
the nervous system.  
A recent study has taken advantage of more precise methodologies to quantify editing 
profiles in C57Bl/6 mice exposed to antidepressants and antipsychotic drugs [64]. This study 
reported a remarkably consistent reduction in editing at the A and B sites in the hippocampus in 
response to the serotonin-selective reuptake inhibitor (SSRI; fluoxetine) and a tricyclic 
antidepressant (amitriptyline) compared to control animals treated with saline. Interesting, these 
studies also included an experiment which indicated that the 5HT2C editing profile of normal 
facility-reared C57Bl/6 mice that had never been exposed to any saline injection regimen had an 
editing profile that was nearly identical to the drug treatment groups [64]. This finding suggests 
that the drug treatment was preventing a change in editing that may have resulted from the stress 
associated with daily handling and saline injections. 
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 Chapter II 
INVESTIGATING THE DYNAMICS OF 5HT2C RNA EDITING PROFILES IN MICE 
 Studying RNA editing for 5HT2C transcripts presents a unique opportunity to examine 
feedback mechanisms that might lead to dynamic changes in A-to-I conversion. The murine 5HT 
system is accessible to manipulation by well characterized pharmacologic and genetic tools. We 
took advantage of some of these tools to test the hypothesis that perturbations in 5HT signaling 
can cause changes in 5HT2C editing profile. In addition to taking advantage of mouse models in 
which components of 5HT circuitry are manipulated, we also took advantage of stress paradigms 
which indirectly affect a variety of CNS circuits including those involving 5HT. However, the 
first step required to study 5HT2C editing was to establish a sensitive and precise method to 
measure RNA editing profiles. First, I will describe the approach we adopted to create an 
accurate, cost and labor efficient method for measuring editing profiles. This approach takes 
advantage of the passively parallel Genome Analyzer sequencing technology developed by 
Illumina (San Diego, CA). We validated this approach and used it to test the hypothesis that 
5HT2C editing is malleable in response to pharmacologic, genetic, or physiological manipulation.        
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Materials and Methods 
RNA analysis 
RNA Extraction 
 Tissue was dissected and mechanically homogenized in TRI reagent (Sigma-Aldrich) using a 
Polytron homogenizer (Brinkman). RNA was isolated from the TRI reagent mixture according to 
manufacturer’s instructions and stored at -80oC until further analysis.  
High Throughput Multiplexed Transcript Analysis (HTMTA)  
To characterize accurately the profile of edited 5HT2C isoforms present in a tissue sample it 
would be ideal to sequence every RNA species in the sample, thereby directly observing the 
distribution of edited 5HT2C RNA isoforms. As this is not a feasible approach, due to 
technological limitations, we indirectly quantified editing by sequencing cDNAs generated from 
5HT2C transcripts. RNA editing profiles were determined by high-throughput sequence analysis 
(Figure 2) as previously described using random primers and avian myoblastosis virus reverse 
transcriptase (Promega) for initial cDNA synthesis followed by five cycles of PCR amplification 
with Phusion high-fidelity DNA polymerase (New England Biolabs) and 5HT2C-specific primers 
containing either T3 or T7 RNA polymerase promoter extensions for the sense (5’-
ATTAACCCTCACTAAAGGGAGCTGGACCGGTATGTAGCA-3’) and antisense (5’-TAAT-
ACGACTCACTATAGGGGGATACGAACTGATACACCTATAG-3’) primers, respectively. 
Unincorporated single-stranded primers were digested with Exonuclease I (New England Bio-
labs) and a second round of amplification (25 cycles) was performed with a common antisense 
primer (5’-CAAGCAGAAGACGGCATACGAGCTCTTCCGATCTTAATACGACTCACTA-
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 TAGGG-3’) matching the 20 nucleotide (nt) T7 RNA polymerase promoter (underlined) with a 
34-nt adapter extension that can anneal to the Illumina flowcell surface (Adapter B) and one of 
twenty-four sense primers (5’-AATGATACGGCGACCACCGAGACTACACTC—TT—C-
CTACACGACGCTCTTCCGATCTNNNNNNATTAACCCTCACTAAAGGGA-3’) matching 
the 20 nt T3 RNA polymerase promoter (underlined) containing both a 6-nt index sequence 
(NNNNNN) for sample identification and a 58-nt adapter extension (Adapter A) for high-
throughput Illumina sequencing (Bentley, 2008). PCR amplicons (258 bp) were resolved on a 
2% agarose gel, purified from excised gel slices using the Wizard SV Gel and PCR Purification 
Kit (Promega, Madison, WI) and mixed with up to 24 other products containing unique barcodes 
before single-end sequencing (100 bp) using the Illumina Hi-seq 2000 system (Illumina, San 
Diego, CA). Sequence reads were aligned to one of thirty-two 5HT2C reference sequences (5’-
NNNNNNATTAACCCTCACTAAAGGGAGCTGGACCGGTATGTAGCARTRCGTRRTCC-
TRTTGAGCATAGCCGG-3’) where the five editing site(s) were represented by a purine (R) 
and only those sequences in which the index sequence was identifiable and the sequence reads 
precisely matched the reference sequences were included for further analysis. The relative 
expression of each edited 5HT2C isoform was calculated as the percentage of reads matching a 
specific, edited isoform divided by the total number of 5HT2C reads for all isoforms. 
 
Quantitative Real-time PCR 
Gene expression was analyzed using Taqman Probe-based real time PCR (Applied Biosystems). 
All experiments used a 6-carboxy-2',4,4',5',7,7'– hexachlorofluorescein (HEX)-labeled 18S 
rRNA probe and primer sets for an internal standard (4319413E). For analysis of 5HT2C 
expression, a 6-carboxyfluorescein (FAM)-labeled probe and primer set (Mm00434127_m1) 
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 which detected sequences common to all three 5HT2C splice variants located near the 5’-end of 
the mature 5HT2C mRNA transcript was employed. Factor V (F5) expression was used as a 
proxy measure for the extent of choroid plexus contamination in each RNA sample. F5 was 
detected using a FAM-labeled Taqman probe and primer set (Mm00484202_m1). For 
quantitative (q)RT-PCR, first strand cDNA was synthesized with random primers using the 
High-Capacity Reverse Transcription Kit and expression was analyzed according to 
manufacturer’s instructions for Taqman real-time PCR (Applied Biosystems) on a CFX96 
platform (Biorad, Hercules, CA) . Amplification efficiencies were determined by PCR miner 
algorithm [65] and data was analyzed by CFX manager (Biorad, Hercules, CA).   
Drug Treatment 
 Mice received daily intraperitoneal injections of either 100 mg/kg para-
chlorophenylalanine (pCPA) dissolved in sterile saline or vehicle alone for seven consecutive 
days at 8:30am. On the seventh day, the mice were decapitated and brain hemispheres were 
separated for chemical analysis or RNA extraction. A separate cohort of mice received daily 
intraperitoneal injections of either fluoxetine, amitriptyline, olanzapine, or vehicle for 28 
consecutive days, as described [64].  
Stress protocols 
Restraint Stress 
 Physical stressors cause changes that directly affect physiology and behavior. To test the 
hypothesis that stress might affect RNA editing at 5HT2C transcripts we used the well-validated 
stress model of tube restraint for 30 minutes [66]. All mice were either facility-reared or acquired 
after adrenalectomy from The Jackson Laboratory (Bar Harbor, ME). Beginning at 6-8 weeks of 
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 age, the mice were subjected to 30 minutes of daily restraint in 50 ml conical tubes which had 
been modified to include holes for adequate ventilation during the restraint procedure. Tube 
restraint was performed daily at 8:30 am for durations ranging from 2 to 28 days, depending on 
the experiment.  
Maternal Separation  
To mimic early-life stress in humans, we utilized the maternal separation (MS) paradigm, 
an established animal model of vulnerability to development of enhanced stress responsiveness 
in adulthood [67-70]. Maternal separation began on postnatal day 1 (P1) and occurred daily for 8 
hours until P14. C57BL/6J males and females were mated randomly at 8 weeks of age and males 
were removed from the cage following overnight pairings so that females were housed singly 
throughout pregnancy and parturition. Maternal separation consisted of first removing the dam, 
followed by the pups, from the home cage and placing them into separate clean cages with clean 
bedding. During MS, pups were kept in rodent incubators maintained at 30°C to preserve their 
nesting temperature. Control litters were left completely undisturbed from birth (P0)-P14. 
Animals were euthanized at P15 by cervical dislocation under anesthesia and specific brain 
regions were dissected (hippocampus, striatum, cortex and hypothalamus). 
Brain Dissection 
All dissections were performed as follows, unless otherwise noted. Brains were removed from 
the skull and placed on a cool dental wax surface. First the hypothalamus was identified by 
visual inspection and removed from the ventral surface of the brain for processing. Next the 
brain was sliced in the coronal plane at the anterior commissure using a sharp razor blade to 
separate the forebrain from the midbrain, while keeping the striatum and hippocampus intact. 
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 The cortex was then removed from the caudal half exposing the hippocampus, which was 
removed for further processing. Next the striatum and frontal cortex were removed from the 
rostral portion of the brain for processing and the remainder of the brain tissue was discarded, 
unless otherwise noted.   
Statistics 
 For standard statistical analysis, Student’s T-test was used for all pairwise comparisons. 
Analysis of variance (ANOVA) was used for comparison of multiple groups and the Bonferroni 
post-hoc test was used for comparison of individual groups. 
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Figure 2. Methodology for quantifying RNA editing profiles using massively parallel 
sequencing. A) Summary of the high-throughput multiplex transcript analysis method used 
to determine the profile of edited transcript variants in an RNA sample. First, cDNA is 
synthesized and subjected to 5 cycles of PCR amplification with primers designed to 
amplify the transcript of interest. These primers contain 5’ tails with T3 (sense) and T7 
(antisense) promoter consensus sequences. Then, a second PCR reaction is performed using 
“universal barcoded primers” primers targeted to these 5’ tail sequences. This set of 
primers contain 5’ tail sequences that allow for sequencing on the Illumina Genome 
Analyzer platform as well as unique 5 nucleotide “barcode” identifier sequences that will 
be used for disambiguation of sequence data. B) Summary of the informatics protocol used 
in analysis of sequence data. 
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 Results 
Measuring RNA editing using high-throughput multiplexed transcript analysis (HTMTA) 
Accurately measuring the profile of edited 5HT2C transcript variants in a sample was 
historically difficult because the number of possible combinations of editing required extensive 
sampling of transcript sequences. PCR amplification is useful for generating a representative 
pool of DNA that can be directly bulk sequenced by the Sanger method. However, this 
sequencing method only provides a proximal representation of the extent of inosine conversion 
at each respective site and provides no information about the combinations of editing that might 
occur within individual transcripts. A method for simultaneous detection of editing status at all 
five sites is necessary for investigating linkage between editing at particular sites as well as to 
accurately predict the protein isoforms that are encoded. This was accomplished by ‘shotgun 
subcloning’ representative 5HT2C cDNA pools into plasmid vectors that could then be grown in 
bacteria and directly sequenced. To estimate the distribution of different isoforms with the 
precision required to systematically study the RNA editing dynamics, a large number of clones 
had to be sequenced. Circumventing the need to subclone, pick, and sequence individual 
bacterial colonies we developed a method which takes advantage of parallel short read ‘deep-
sequencing’ technology available on the Illumina Genome Analyzer platform. This technology 
allows for direct sequencing of any DNA fragment containing appropriate adapter sequences 
which facilitate application of DNA to the sequencing instrument. We originally described this 
targeted high-throughput multiplexed transcript analysis (HTMTA) process in 2010 [24]. Since 
then, additional multiplexing tools and protocol modifications have been made to make the 
technique more versatile and cost-efficient as described in the Materials and Methods. Once we 
established a protocol for amplifying and sequencing 5HT2C transcripts on the Illumina platform 
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 we set out to verify that this approach was both valid and reproducible. In order to do this we had 
to verify that our methods did not introduce any bias to the editing profile, establish the expected 
error rate, and demonstrate reproducibility. The following results provide strong evidence that 
HTMTA is indeed a useful and accurate way to make precise estimates about the editing profile 
of transcripts in an RNA sample.   
Amplification Bias 
 Non-biased PCR requires that all potentially limiting reaction components are in excess 
to the template being amplified at every cycle of amplification. To verify that no component of 
the PCR that we use to generate the sequencing library was limiting and thus contributing to 
biased amplification we had to establish that the protocol is performed within the linear range of 
PCR amplification. No differences in editing profile were observed when a cDNA sample was 
subjected to either 19, 22, 25, 28, 31, or 34 cycles suggesting that the 28 cycles used in all 
subsequent experiments was well within the linear amplification range. 
Error rate 
 The next step for validating this technique was to establish the error rate generated by 
polymerase error, sequencing errors, and RNA sampling. To determine the false discovery rate 
of our protocol we amplified the editing site from a single recombinant 5HT2C-INI clone using 
the HTMTA primers and sequenced the resulting amplicon. We observed a “non-A” base call at 
the editing sites with a frequency of 0.1%, indicating that our “error rate” for detecting editing 
events at each respective site is 0.1% and that our error rate for identifying predicted coding 
isoforms is 0.25%.  
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Figure 3: Determining linear range of PCR. Extent of editing detected at each site in an 
RNA sample extracted from a single 129S6 mouse brain as determined using a range of PCR 
cycle numbers from 19-24. Results indicate that all cycle protocols are within the linear 
range of PCR amplification.  
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 To assess the reproducibility and RNA sampling sufficiency, the HTMTA protocol was repeated 
three times using a single RNA sample generated from C57Bl/6 whole brain. The mean 
percentage of editing at each site (± SEM) observed in these studies was: A site= 79.48 ± 0.34; B 
site= 68.16 ± 0.35; E site= 4.01 ± 0.09; C site= 23.91 ± 0.34; and D site= 62.98 ± 0.15 (Figure 3 
and Table 2). These results indicate that the extent of technical reproducibility is similar to the 
absolute error rate, providing strong evidence that the HTMTA paradigm is a reliable tool for 
measuring edited isoform profiles. 
 
Establishing Base Line 5HT2C editing profiles 
  Previous efforts to establish the edited 5HT2C isoform profile in the brain yielded 
inconsistent results suggesting that a wide variability within brain regions and species may exist, 
even between littermates. One interpretation of these results is that sensitive and dynamic 
feedback systems regulate the expression of precise editing profiles in different physiological 
contexts. Conversely, it could also indicate that editing is a largely stochastic event and fitness is 
not greatly influenced by tight control of 5HT2C editing patterns. With a tool developed that 
allows efficient and accurate quantification of editing profiles, we began to interrogate 5HT2C 
editing patterns in a more systematic manner. 
Reproducibility and inter-animal variability 
 As noted above, previous attempts to characterize 5HT2C editing profile in littermates 
yielded variable results, indicating high inter-animal variability. It was important to confirm this 
finding with the more accurate HTMTA approach to establish a baseline expectation for 
variability in whole brain editing profiles. We used five samples prepared from total RNA 
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 Figure 4. Comparison of RNA editing patterns using HTMTA and pyrosequencing 
methodologies. The extent of editing in five different whole brain RNA samples from male 
C57Bl/6 littermates was determined using HTMTA (top) or the pyrosequencing of 100 cDNA 
clones (bottom).   
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 Isolated from the whole brains of 6 week old, male C57Bl/6 mice. Each RNA sample was 
analyzed by the traditional method of subcloning RT-PCR amplicons and pyrosequencing ~100 
clones for each mouse. The editing profile of each sample was then quantified by the HTMTA 
method, which effectively sequences millions of clones. The results of the pyrosequencing 
approach, which only examined 100 clones per RNA sample, indicated significant inter-animal 
variability. The standard errors are 3% of the mean at the A site, 3% of the mean at the C site, 
33% of the mean at the E site, 18% of the mean at the C site and 3% of the mean at the D site 
(Figure 4). However, when the same samples were analyzed by HTMTA, the results showed 
essentially no inter-animal variability with the highest standard error at the C site being 0.9% of 
the mean; the remaining sites had variability that was less than the 0.1% of the predicted error 
rate of the assay (Figure 4). These results indicated that whole brain editing profiles were 
actually remarkably similar in each C57Bl/6 mouse brain samples providing evidence for tight 
regulation of A-to-I editing for 5HT2C transcripts.  
Editing in inbred mice 
Isogenic mouse lines have been generated by decades of commercial and academic facility 
breading. They are valuable tools for studying the influence of genes on physiology because they 
contain only one allele (albeit two copies) of every gene. This means each strain of mouse is 
essentially a genetically identical clone of its siblings and parents. In some cases, this has 
allowed for the identification of specific genes which influence or dictate relevant phenotypes. 
To examine potential strain-specific differences in 5HT2C editing, we decided to look at whole 
brain editing profiles of several inbred mouse lines to see if different editing profiles correlated 
with any particular mouse strain. RNA extracts were prepared from the brains of normal facility-
reared C57Bl/6J, Balb/cJ, DBA/2J, and 129S6 mice and 5HT2C editing profiles were
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Figure 5. Analysis of 5HT2C mRNA profiles 
of different inbred mouse strains. HTMTA 
analysis of site-specific editing patterns from 
whole brain RNA isolated from C57Bl/6J, 
129S6, DBA/2J, and BALB/cJ mouse strains 
(2-way ANOVA n=5, *p<.0001). Error bars 
indicate SEM. 
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Figure 6. Analysis of brain region-specific 5HT2C RNA editing 
profiles in C57Bl/6J mice. 5HT2C editing profiles were determined 
by HTMTA from RNA isolated from whole brain (WB) and 
dissected brain regions including cortex (Ctx), striatum (Str), 
hippocampus (Hip), hypothalamus (Hyp), olfactory bulb (OB) and 
choroid plexus (CP) (means compared to whole brain editing 
profile by t-test; n≥4, ∗p<0.05,∗∗p<0.01, ∗∗∗p<0.001). Errors 
indicate SEM. 
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 analyzed by HTMTA. No differences were observed between C57Bl/6J, Balb/cJ, and DBA/2J 
mice indicating that none of these mice harbored alleles that led to differences in whole brain 
5HT2C editing profiles. Significantly decreased editing at the A and B sites and increased D site 
editing was observed for 129S6 mice compared to the other three strains (Figure 5). It should be 
noted however, that this effect may reflect changes which are manifest in selective brain regions 
and characterization of editing profiles in discrete regions for each of these mouse strains may be 
needed for a better understanding of these inter-strain differences.                
Editing profiles in various mouse brain regions 
 The previously described studies provided us with a new understanding concerning the 
relative inter-animal consistency for 5HT2C editing profiles. To capitalize on this consistency, 
paired with the accuracy and reproducibility of this HTMTA paradigm, we focused upon 
quantification of editing profiles from more discrete brain regions in at least one of these 
isogenic mouse lines. For these experiments we dissected olfactory bulb, hypothalamus, 
hippocampus, striatum, frontal cortex, and choroid plexus from C57Bl/6J mice and compared the 
editing profiles to those observed in whole brain RNA extracts (Figure 6). While we observed 
slight differences in the relative levels of edited 5HT2C isoforms in dissected brain regions from 
those observed in whole brain, the greatest differences were observed in RNA samples isolated 
from the choroid plexus. This ependymal tissue, which lines the ventricles, participates in 
cerebral spinal fluid (CSF) production and expresses the greatest levels of 5HT2C mRNAs 
compared to surrounding neural tissues [41]. Importantly, ADAR1 expression is undetectable in 
choroid plexus by in situ hybridization [41, 71], which is reflected in a near complete deficiency 
of editing observed at the A and B sites. Likewise, slight elevations in the editing 
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  efficiency are observed at the D site supporting the ADAR competition model for modulating 
site-selective editing efficiency. These findings provide a useful baseline for interrogating the 
potential dynamics of RNA editing for 5HT2C receptor transcripts in response to physiologic, 
pharmacologic, and genetic manipulations. 
Editing in animals with experimentally-manipulated 5HT systems  
Measuring editing in the face of genetic manipulations of the 5HT system 
 Genetic manipulation of the 5HT system can be achieved by altering expression of 
enzymes, receptors, or transcription factors regulating different components of 5HT biosynthesis 
and signal transduction. Chronic manipulations of this kind can be expected to result in a variety 
of compensatory changes in circuit dynamics, gene expression and morphology. Genetic models 
with altered 5HT systems represent valuable experimental approaches for testing hypotheses 
relating to 5HT2C RNA editing and associated feedback mechanisms. One possibility is that 
editing can be reduced in conditions of 5HT deficiency to provide compensatory signal tone in 
the form of receptor isoforms with increased constitutive activity. We tested this hypothesis in 
genetic models with ablated 5HT systems or altered 5HT uptake kinetics. 
The most extreme case of central 5HT-deficiency is the Pet1-null mouse. This mouse was 
generated by targeted knockout of the gene encoding the Fev transcription factor (Pet1) [72]. 
This transcription factor is required for development of 5HT neurons; as such, neither 
serotonergic neurons nor 5HT is detected in the adult brain of these mice. We examined the 
5HT2C editing profiles in hippocampus and whole brain RNA samples from Pet1+/+, Pet1+/- , 
and Pet1-/- mice created on a 129sv background and observed no differences in editing for any 
of these groups (Figure 7). These results indicate that in the face of lifelong absence of input 
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 Figure 7. Whole brain editing profiles from animals with 
genetically-modified 5HT systems. HTMTA was used to 
determine 5HT2C editing profiles in RNA isolated from whole 
brains of mice homozygous for a hyperactive serotonin transporter 
variant (Gly56Ala) and mice engineered to be homozygous null for 
the Fev1 transcription factor (Pet1-/-). A t-test revealed no 
significant differences in editing between the mutants and wild type 
mice at any of the five editing sites (n>3).Error bars indicate SEM. 
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  from 5HT neurons, no alterations in editing are elicited, suggesting that 5HT2C editing is not 
likely to be regulated by factors released by serotonergic neurons. However, interpretation of 
knockout studies can be complicated by the induction of compensatory mechanisms. To address 
this hypothesis further we sought a more nuanced model of 5HT signaling dysfunction in an 
attempt to reveal a role for 5HT signaling in the regulation of RNA editing.  
We took advantage of a mouse model harboring a much less severe manipulation of the 
5HT system to test the hypothesis that synaptic 5HT levels influence the expression of edited 
5HT2C isoforms. A serotonin transporter (SERT) variant identified in human autism patients, 
Gly56Ala, was knocked into the endogenous locus of 129S6 mice by hologous recombination in 
embryonic stem cells. These mice are viable and display normal growth patterns, but harbor a 
hypermorphic SERT allele which is predicted to clear 5HT more rapidly from the synapse [73]. 
These mutant animals provide an opportunity to analyze the effect of dysregulated synaptic 5HT 
rather than an absence of central 5HT. We compared whole brain editing profiles from mutant 
SERT Gly56Ala mice to those of wild-type animals, once again revealing no significant changes 
in editing. These experiments do not support the idea that 5HT2C editing may represent a 
homeostatic mechanism whereby 5HT2C receptor signaling is stabilized in the face of changing 
synaptic serotonergic input. 
5HT2C editing after pharmacologic depletion of serotonin 
In light of these findings, we thought it was important to examine whether acute 
depletion of 5HT could affect 5HT2C editing profiles and circumvent potential compensatory 
mechanisms that may result from chronic 5HT dysregulation. For these studies, we injected 
C57Bl/6J mice with p-chlorophenylalanine, an irreversible inhibitor of tryptophan hydroxylase 
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Figure 8. Quantitative analysis of 5HT2C 
RNA editing after 5HT depletion. Animals 
injected with pCPA or vehicle for 7 
consecutive days were sacrificed and RNA 
was extracted from one cerebral hemisphere, 
while the other was subjected to HPLC 
analysis to determine tissue 5HT levels. 
Student’s T-test revealed no significant 
differences between treatment groups (n=5). 
Error bars indicate SEM. 
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(TH), the rate limiting enzyme for 5HT synthesis [74]. After seven consecutive days of 
injections, whole brains were removed and the hemispheres separated. One hemisphere was used 
for HPLC analysis to determine the extent of 5HT depletion, while the other was processed for 
RNA editing analysis by HTMTA. Despite ~80% reduction in 5HT levels after drug treatment, 
no alterations in 5HT editing profiles were observed. These results further support the idea that if 
some active process is maintaining editing profiles in the narrow ranges observed for isogenic 
mice, it appears unlikely to require either serotonin or serotonergic neurons. Although these 
studies do not rule out the possibility that serotonergic tone might actively influence editing in 
discrete nuclei, further characterization of editing profiles in specific cell types and brain regions 
will be required to address such details of editing dynamics.  
5HT2C editing in mice after exposure to common psychiatric medications 
5HT2C receptors are thought to be important targets of antipsychotic, and antidepressant 
drugs which may act by altering 5HT signaling [62]. Recent studies have suggested that mice 
treated with these agents can affect 5HT2C editing profiles based upon analyses using a high-
throughput sequencing strategy similar to that described in Figure 2[64]. The authors reported 
that when the edited isoform profiles were characterized in RNA samples isolated from the 
hippocampus of antidepressant-treated animals, a significant increase in A and B site editing was 
observed. This finding was based on the fact that the average extent of editing at the A and B 
sites was much higher in antidepressant-treated mice than control animals injected with vehicle 
(saline) alone. Upon careful examination of this observation, it became clear that the extent of A 
and B site editing in the hippocampus of saline-treated animals was actually much lower than 
untreated mice. In fact, the levels of editing reported for antidepressant treated mice in this study 
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Figure 9. Effect of 28 day saline injection on hippocampus editing. A) Hippocampal 
editing profile of normal facility-reared wild-type mice as determined by high-throughput 
sequencing of RT-PCR amplicons. B) Hippocampal editing profile of mice treated with 
28 consecutive days of saline show much lower editing at the A and B sites. The 
magnitude of this reduction is tempered when the saline injection also contains fluoxetine 
or amitriptyline, suggesting that the stress from daily handling and saline injection may 
modulate editing at the A and B sites and that this effect could be blocked by two classes 
of antidepressant drugs (adapted from Abbas, et al 2010 [63]). 
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 were nearly identical to the levels displayed by untreated C57Bl/6 mice in our laboratory (data 
not shown). One explanation for this finding is that the antidepressants were having a protective 
effect on reduced editing of the A and B sites that was elicited by the stress from daily handling 
and saline injection. Indeed, handling and saline injections can potently activate the 
hypothalamic-pitutitary-adrenal (HPA) axis in mice [75] and these findings parallel extensive 
literature providing evidence that antidepressants promote resilience in the face of stress [76]. 
This paradigm provided an exciting avenue for testing the hypothesis that stress could modulate 
5HT2C editing profiles in the mouse brain and that antidepressant medications could work to 
restore 5HT2C editing profiles to the unstressed state. 
Effects of stress on 5HT2C editing 
 The initial findings outlined above suggested that stress from daily handling and 
intraperitoneal injection could reduce 5HT2C editing at the A and B sites, especially in the 
hippocampus. If such changes were reproduced using a better validated model of stress, it could 
provide new insights concerning the effects of stress on physiology and behavior and possibly a 
novel mechanism for antidepressant action in the central nervous system. In addition, it would 
provide a paradigm for dissecting the molecular mechanisms regulating 5HT2C editing and the 
behavioral effects resulting from these changes. 
Restraint stress time-course analysis 
Tube restraint is considered a mild to moderate stressor for mice that leads to elevated 
glucocorticoids and stereotypical behaviors which vary depending on genetic background [77, 
78]. In initial pilot studies, C57Bl/6 mice were subjected to 30 minutes of daily tube restraint at 
8:30 am for 2 days, 7 days, 14 days, or 21 days. After final stress exposure, animals were 
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 euthanized, RNA was isolated from dissected cortex, hippocampus, striatum, hypothalamus and 
amygdala and 5HT2C editing profiles were determined by high-throughput sequence analysis. 
Results from these studies reproduced findings observed with daily injection of saline alone, 
supporting the hypothesis that stress can modulate 5HT2C editing patterns (Figure 9). Dramatic 
reductions in A and B site editing were observed after 7 days of restraint, selectively in 
hippocampal tissue. These reductions reached a maximum after 14 days of restraint stress and 
began returning to baseline after 21 days of consecutive stress. One model implied by these 
results is that acclimation to a stressor parallels changes in editing where a molecular link 
between the psychocognitive effects of stress and changes in neurotransmitter receptor 
expression/signaling could provide important insights concerning stress adaptation.   
To pursue these findings further, we performed more detailed time-course analyses to investigate 
the possibility that these effects were either transient or persistent. The hypothesis that editing 
changes as a result of stress, and then returns to normal after acclimation, was assessed by 
determining if editing returned to baseline after cessation of daily restraint (Figure 11). Since the 
most robust effects of restraint were observed after 14 consecutive days, we used 14-day restraint 
as a baseline and allowed animals to recover undisturbed for 24, 48, or 96 hours in normal 
housing. Results from this analysis indicated that animals stressed for 14 days still demonstrated 
the expected reductions in A and B site editing in the hippocampus after 24 hours of recovery. 
After 48 hours of recovery however, A and B site editing efficiency began returning to normal, 
and after 96 hours, the 5HT2C editing profile in the hippocampus of stressed mice was 
indistinguishable from that observed in unstressed animals. These findings demonstrated that that 
the effects of uncontrollable stress on hippocampal 5HT2C editing were transient manifestations  
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Figure 10. Effect of restraint stress on brain 5HT2C editing 
efficiency. A) Results from pilot studies investigating the effects of 
daily restraint stress on 5HT2C editing profiles. Editing efficiencies 
were determined by comparing the extent of editing after exposure 
to restraint stress to unstressed controls (2-way ANOVA n=4 * 
p<.01, **p<.001). B) Effect of 14 consecutive daily exposures to 
30 minutes of tube restraint on site-selective 5HT2C editing in RNA 
isolated from dissected brain regions. Error bars indicate SEM 
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Figure 11. Dynamics of recovery from stress on 5HT2C 
editing profile in the hippocampus. 5HT2C editing profiles 
were determined in hippocampus of mice subjected to 14 days 
of restraint stress followed by up to 7 days of unstressed 
recovery. Error bars represent SEM. Statistical analysis is not 
shown because data is confounded by known artifacts as 
discussed in text.   
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that subside when the animals are no longer being exposed to the stressor or has learned to cope 
with the stressor in some other way. 
Strain specificity of stress effects  
Different stress coping mechanisms have been identified in inbred mouse strains of disparate 
genetic background. One example of such disparate stress coping behavior is observed when 
comparing stress-responsiveness in Balb/c and C57Bl/6 mice. C57Bl/6 animals generally 
respond to stress and novel environments with hyperactivity, whereas Balb/c mice respond with 
hypoactivity and a characteristic stretching and sniffing behavior [79]. To determine if the effects 
of stress on hippocampal 5HT2C editing profiles were strain-specific and potentially related to 
different coping mechanisms, we exposed Balb/c animals to 14 days of consecutive tube restraint 
and characterized the 5HT2C editing patterns in RNA samples isolated from distinct brain 
regions. Results from these analyses indicated significant reductions in 5HT2C editing at the A 
and B sites, similar to that observed in stressed C57Bl/6 mice. Surprisingly, we also observed 
editing profiles in the hippocampus from some unstressed Balb/c mice that resembled the profile 
expected after stress exposure (Figure 12A). One potential explanation for this unexpected 
finding involves increased sensitivity to an unidentified environmental stressor experienced by 
some of the mice in their home cage which was leading to the changes in 5HT2C editing patterns. 
Indeed some investigators have suggested that Balb/c mice represent a model of chronic anxiety 
[79]. A chronic anxious state might result in the observed alteration for editing profiles in Balb/c 
mice, even when they are not subjected to restraint. 
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 Restraint stress effects on editing in adrenalectomized mice 
After generating initial data concerning the temporal dynamics of stress-induced changes 
in A-to-I conversion, we wanted to identify the signaling mechanisms leading to the observed 
alterations in 5HT2C editing. Stressors activate the hypothalamic-pituitary-adrenal (HPA) axis 
leading to elevated glucocorticoid release from the adrenal gland and many of the effects of 
stress on CNS function are thought to result from elevated glucocorticoid levels. Hippocampal 
neurons express high levels of glucocorticoid receptors and elevated glucocorticoids in mice 
have been correlated with changes in neuronal physiology, dendritic morphology, and reduced 
hippocampal volume [76]. Surgical removal of the adrenals has been shown to eliminate stress-
induced glucocorticoid stimulation while preserving initial central responses to stress exposure. 
By subjecting adrenalectomized (Adx) mice to the tube restraint paradigm, we could address the 
possibility that changes in editing were dependent upon intact glucocorticoid signaling. 
Adrenalectomized animals were acquired from The Jackson Laboratory (Bar Harbor, Maine) and 
shipped to the Vanderbilt animal housing facility where they were allowed to acclimate for 7 
days. After acclimation, a portion of the animals were sacrificed and dissected whole 
hippocampus was harvested for RNA isolation to determine whether adrenalectomy itself led to 
changes in baseline editing profiles. No differences between sham-Adx and Adx mice were 
observed (Figure 12B). The sham and Adx animals responded to tube restraint with similar 
behaviors including increased micturition, defecation, and periodic struggling. Furthermore, 
analysis of 5HT2C editing patterns in the hippocampus revealed a similar reduction in A and B 
site editing after 14 days of daily restraint, suggesting a glucocorticoid-independent mechanism 
of stress that was driving the observed molecular plasticity. 
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Figure 12. Results from 
initial quantitative 
analysis of 5HT2C editing 
patterns in response to 
genetic and surgical 
manipulation. Site-
selective RNA editing 
patterns were quantified 
in Balb/c mice subject to 
7 days of tube restraint 
(A), for control (sham) 
and adrenalectomized 
(Adx) C57Bl/6 animals 
after 2 or 7 days of tube 
restrain (B) and in mice 
null for the expression of 
Pet-1 (C). Error bars 
represent the SEM.  
Statistical analysis is not 
shown because data is 
confounded by known 
artifacts as discussed in 
text.   
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 Effects of complete 5HT neuronal loss on stress induced editing dynamics  
The apparent absence of a role for glucocorticoids in the observed stress-dependent 
alterations in 5HT2C editing profiles motivated us to pursue an alternative hypothesis where 
changes in signaling from serotonergic neurons were driving reductions in site-selective 5HT2C 
editing. For these studies, we took advantage of the Pet-1-null animals that have been shown to 
lack serotonergic neurons [72]. Homozygous Pet-1-null animals were subjected to 14 
consecutive days of tube restraint (30 min/day) before analysis of hippocampal 5HT2C editing 
patterns. Surprisingly, no changes in A or B site editing were observed in these mutant mice 
(Figure 12C), indicating that although stress-dependent changes on 5HT2C editing were 
glucocorticoid-independent, they required the presence of 5HT neurons.  
Effects of maternal separation on 5HT2C editing profile 
To determine whether other commonly employed experimental stressors also might affect 
5HT2C editing, we used perinatal maternal separation [80]. For these studies mice were removed 
from their mothers and individually housed for 6 hours each day from postnatal day 1 (P1) to 
P14. Mice were sacrificed on postnatal day 15 and the hippocampus was removed for 
quantitative analysis of 5HT2C editing. Results from this study indicated significant inter-animal 
variability, where some animals appeared to have reduced A and B site editing in the 
hippocampus, while others appeared to have normal editing profiles. The overall result indicated 
that the mean editing extent was not different between the two groups.  
Monitoring choroid plexus contamination 
 At this point several inconsistencies in the data were beginning to draw our attention. For 
example, initial pilot studies indicated that the effects of stress on editing were maximal at 14  
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Figure 13. Quantitative analysis of early-life stress on 5HT2C 
editing patterns. The effects of daily maternal separation (MS) 
from P1-P14 on hippocampal 5HT2C RNA editing profiles were 
determined. Error bars represent SEM and a t-test comparing the 
mean extent of editing did not reveal a significant difference at any 
site.  (p>.05) Error bars represent SEM. 
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 days and then returned to normal, even in the face of continued daily restraint. However, the 
mice in the Abbas study still showed extensive reductions in A and B site editing, even after 28 
days of saline injection [64]. Furthermore, no increases in ADAR2-selective D site editing were 
observed that could result from stress-induced decreases in ADAR1 activity/expression. Despite 
the reproducibility of our stress-induced changes in 5HT2C editing in initial studies, as we 
attempted to employ larger mouse cohorts, inconsistent results were obtained. Many of the 
stressed animals appeared to have normal hippocampal editing profiles, while some unstressed 
mice displayed editing profiles similar to that observed after 14 days of tube restraint. 
Several brain regions, including hippocampus, have close proximity to ventricles which 
contain choroid plexus tissue. This ependymal tissue, which plays a critical role in the production 
of cerebral spinal fluid (CSF) expresses high levels of 5HT2C mRNA and receptor protein 
relative to surrounding neuronal tissue [41]. Furthermore, 5HT2C editing patterns are unique in 
the choroid plexus (CP), where significantly reduced editing is observed at the A and B sites 
[81]. Several studies have observed profound alterations in hippocampal morphology and 
volume resulting from exposure to stress [82] [80].  For this reason, we wanted to test the 
possibility that our observed changes in 5HT2C editing patterns did not result from stress-
dependent alterations in hippocampal or choroid plexus morphology causing tissue 
contamination during routine brain dissection. To quantify the extent of choroid plexus 
contamination, we used real-time RT-PCR to quantify an RNA target that is highly-enriched in 
choroid plexus, but absent from surrounding brain tissue, coagulation factor V (F5) [41]. Results 
from this analysis revealed that the observed reduction in 5HT2C editing at the A and B sites was 
correlated with the amount of F5 transcript present in the RNA sample (Figure 14), providing 
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 evidence that the observed stress-dependent reductions in editing were actually an artifact of 
choroid plexus carryover during dissection and tissue isolation.  
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Figure 14. Expression of the choroid plexus marker, 
Coagulation Factor V (F5), in hippocampal tissue. Linear 
regression analysis reveals a significant correlation between % 
editing at the A site and F5 expression (p<.0001) revealing that 
choroid plexus contamination is a major factor contributing to the 
extent of editing observed in each sample.  
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 Discussion 
The results of these studies provide convincing evidence that 5HT2C RNA editing is 
remarkably stable in adult animals and that the average editing profile in most brain regions is 
similar to that observed in the whole brain. The one major exception to this is the editing profile 
observed in choroid plexus tissue where an absence of ADAR1 expression leaves the A and B 
sites essentially non-edited [41]. The role of 5HT2C receptors in choroid plexus has not been 
adequately explored and is not well understood. It is interesting to speculate a role for 5HT2C 
constitutive activity in the choroid plexus that might oblige the high expression of constitutively 
active less-edited receptor isoforms in this tissue.  More importantly however, is the observation 
that ventricular proximity and accidental contamination of samples with choroid plexus tissue 
can lead to inaccurate estimates of editing extent in brain tissue samples.  This is an issue that 
needs to be considered when interpreting 5HT2C editing data.   
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  Chapter III 
CHARACTERIZING 5HT2C EXPRESSION IN PRADER-WILLI SYNDROME 
The 5HT2C Receptor and Prader-Willi Syndrome 
A number of observations in rodents and humans have demonstrated that the 5HT2C 
receptor is a key regulator of feeding behavior and metabolism [50, 83]. The 5HT2C receptor is 
expressed by pro-opiomelanocortin (POMC) expressing neurons in the arcuate nucleus of the 
hypothalamus and receptor activation directly stimulates release of melanocortins from these 
neurons to potently suppress hunger [84]. Furthermore, the appetite suppressive action of the 
non-specific serotonin releaser, d-fenfluramine, appears to be mediated by 5HT2C receptors 
specifically in POMC neurons. This was confirmed in studies where hyperphagia and d-
fenfluramine insensitivity in 5HT2C-null animals was corrected by selectively re-expressing 
5HT2C transcripts in POMC neurons using a POMC-Cre based system with a conditional STOP-
FLOX-5HT2C allele [83]. These findings led to the development of Lorcaserin [85], a selective 
5HT2C agonist currently marketed by Arena Pharmaceuticals for appetite suppression in obese 
patients. However, the efficacy of Lorcaserin as a therapeutic is tempered by an unfavorable side 
effect profile of this drug, requiring the use of low doses with marginal effects on appetite.  
Mice engineered so that they solely express the VGV isoform of the 5HT2C receptor have 
been developed by several groups [24, 25] to study the importance of 5HT2C editing and the 
physiological consequences of solely expressing the receptor isoform with the least constitutive 
activity. These animals display several characteristics of a human genetic disorder known as 
Prader-Willi Syndrome (PWS), as well as a number of similarities to construct valid mouse 
models of PWS [51]. Some of the more prominent features observed are a failure to thrive and 
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 severe hypotonia in infancy, adult onset hyperphagia, and neonatal lethality on a C57Bl/6 
background. The precise mechanism conferring these phenotypes is unknown, but it may be 
related to abnormal regulation of 5HT2C expression in the CNS, which is apparent in these 
animals. Specifically, mutant animals express 5HT2C mRNA at similar levels to wild-type 
C57Bl/6 mice, whereas receptor protein levels were increased by 40-70 fold based upon western 
blotting, saturation binding, and autoradiographic methodologies [24, 25]. Likewise, VGV mice 
display heightened sensitivity to drugs targeting the 5HT2C receptor. Administration of 5HT2C 
agonists causes an immediate onset of seizures resulting in death at doses that only mildly 
suppress feeding in wild-type mice [25]. 5HT2C antagonist administration in VGV animals 
results in pronounced hyperactivity reminiscent of the effects observed with high dose 
amphetamine treatment in wild-type animals [86]. When combined with previously identified 
alterations in 5HT2C-mediated behavior in mouse models of PWS (PWS-ICdel) [87] observed 
increases in the editing of 5HT2C transcripts in both a mouse model and human PWS patients 
[86][88] and the known involvement of the 5HT2C receptor in controlling energy homeostasis 
and satiety [83, 89], the presence of PWS-like phenotypes in mice with altered 5HT2C editing 
identifies the htr2C gene as the first locus outside the 15q11-13 imprinted region in which 
mutations can recapitulate multiple aspects of this human genetic disorder. 
Prader-Willi Syndrome is a maternally-imprinted human disorder resulting from a loss of 
paternal gene expression on chromosome 15q11-13 which is characterized by a complex 
phenotype including cognitive deficits, infantile hypotonia and failure-to-thrive, short stature, 
hypogonadism and hyperphagia which can lead to morbid obesity [90, 91]. The diets of PWS 
patients must be carefully regulated or they will become morbidly obese by the time they reach 
adolescence [92]. The prevalence of PWS is estimated to be about 1/20,000 births worldwide and 
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 the syndrome is attributed to the lack of expression of a subset of genes located within an 
imprinted region of chromosome 15 q11.2-q13 [90, 91]. Five protein coding genes, several 
antisense RNAs, and two unique putative small nucleolar RNA (snoRNA) clusters (SNORD115 
and SNORD116) have been identified within this PWS locus [92] (Figure 15). However, the role 
each of these elements plays in the etiology of PWS is not clear, and no single mutation in any 
one of these genes has been associated with all of the features of the syndrome [93-96]. 
Recently, considerable attention has been focused on understanding the role that the non-
protein coding snoRNA clusters might play in the disorder [97]. snoRNAs typically function by 
serving as a guide to direct the site-specific 2’-O-methylation of ribosomal RNAs (rRNAs) or 
small nuclear RNAs (snRNAs) by homology-dependent targeting mechanisms [98]. The 
snoRNAs SNORD115 (HBII-52) and SNORD116 (HBII-85) are present in 42 and 29 copies, 
respectively, within the human PWS region [92], and they are expressed widely in the brain [99]. 
No rRNA or snRNA targets have been identified for either of these snoRNAs, yet a homology 
search revealed that the methylation-targeting sequence for SNORD115 predicts that transcripts 
encoding the 5HT2C receptor are potential targets for snoRNA-mediated 2’-O-methylation [100]. 
Interestingly, the sequence of SNORD115 predicts that it will facilitate 2’-O-methylation at a 
specific adenosine within the 5HT2C transcript which is also one of the sites targeted for A-to-I 
editing (C site). 
The studies described in this chapter are aimed at testing the hypothesis that alterations in 
5HT2C expression will be observed in the brains of PWS patients and that such changes may 
underlie the molecular etiology of this disorder. We used multiple approaches to measure 5HT2C 
RNA levels, alternative splicing patterns, RNA editing profiles, 2’-O-methylation and receptor 
protein expression in dissected brain regions obtained from PWS patients and non-PWS controls. 
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Figure 15. Schematic summary of the Prader-Willi Syndrome (PWS) locus and its putative 
interaction with 5HT2C transcripts. A) A schematic diagram of the chromosomal locus implicated in 
PWS 15q11-13 is presented. Large blue boxes represent maternally-imprinted genes while the red 
circle indicates the location of the imprinting center where CpG methylation occurs on the maternal 
chromosome to silence the maternally imprinted genes. Small blue lines indicate snoRNAs encoded in 
the 3’-untranslated region of the SNURF-SNRPN transcript. B) The human SNORD115 locus 
contains 48 copies of the snoRNA (HBII-52), each containing a region of sequence complementarity 
to the edited region of the 5HT2C transcript. This sequence complementarity predicts 2’-O-methylation 
of the C editing site (red) which is complementary to the base five nucleotides downstream from the 
conserved D-box element (rectangle) in the snoRNA. Loss of expression at this locus due to deletion, 
aberrant methylation, or uniparental (maternal) disomy results in PWS. 
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Methods 
Human Tissue Sample Preparation 
 All human tissue samples were obtained from the NICHD Brain and Tissue Bank for 
Developmental Disorders (Baltimore, MD). Tissue was processed by crushing into fine powder 
while frozen using a ‘Cryo-cup’ grinder and pestle (Biospec Products) and stored at -80o C until 
further processing for RNA, protein or membrane preparations was required. 
Genotyping to confirm PWS diagnosis 
 PWS patients were diagnosed based upon physical examination and generally were not 
confirmed by subsequent molecular genetic analysis. To confirm diagnoses at a molecular level, 
genomic DNA samples from each individual were subjected to analysis by methylation-specific 
multiplex ligation-dependent probe amplification, as described previously [101]. 
RNA Characterization 
RNA extraction 
 Frozen, powdered tissues were homogenized in Trizol® reagent (Life Technologies) and 
total RNA was isolated following the manufacturer’s instructions. 
Quantitative RT-PCR 
5HT2C mRNA expression was determined by quantitative reverse transcription-
polymerase chain reaction (qRT-PCR) amplification using the Assay-On-Demand primer/probe 
set for the human 5HT2C transcript (Hs00168365_m1) and a Vic-labeled primer/probe set 
designed for the human large ribosomal protein transcript, RPLP0 (4326314E) which was used 
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 as an internal loading control. To identify tissue samples contaminated with choroid plexus, 
qRT-PCR was used with a probe for the choroid plexus specific marker human coagulation 
factor V (F5) (Applied Biosystems, Hs00914120_m1). Gene amplification efficiencies were 
calculated using the PCR miner algorithm [65] and data was analyzed using CFX Manager 
(Biorad Laboratories). 
RNA editing profiles determined by HTMTA 
RNA editing profiles were determined by high-throughput sequence analysis as 
previously described [102] and presented in Chapter 1 (Figure 2). 
Alternative splicing of 5HT2C pre-mRNA  
 5HT2C alternative splicing patterns were determined by semi-quantitative RT-PCR using 
primers which amplify all three splice variants (Sense: 5’-TATTTGTGCCCCGTCTGG-3’; 
antisense: 5’-CATGGTGCCCCTAGGACGTCT-3’). Resultant amplicons were resolved on a 
2% agarose gel and ethidium bromide fluorescence was quantified by phosphorimager analysis 
using a Typhoon 9400 and ImageQuant TL software (GE Healthcare). The relative ratio of 
spliced isoforms was calculated by correcting fluorescence values by size ratios of the PCR 
amplicons to normalize for ethidium bromide binding.  
Analysis of 2’-O-methylation in mouse brain RNA 
 A highly sensitive assay was developed to detect low levels of 2’-O-methylation for the 
adenosine at the “C” editing site in 5HT2C transcripts. This assay takes advantage of site directed 
RNAse H cleavage directed by a chimeric DNA-RNA oligonucleotide described by Yu et al. 
[103]. The chimeric oligonucleotide probe rArGrGATTArCrGrUrArUrUrGrCrUrArCrArUrA-
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 rCrC was synthesized and PAGE purified by Integrated DNA Technologies (Coralville, Iowa) 
where bold letters represent deoxynucleosides and the ribonucleosides are shown with an “r” 
before each letter. Either water or 100 pmol of the chimeric probe was mixed with 5 ug of total 
mouse brain RNA extracted from mice genetically engineered to express only the non-edited INI 
isoform in 50 nM NaCl. The mixture was denatured by heating RNA to 90oC for 3 min and then 
annealed by allowing it to cool to room temperature followed by a 20 min incubation on ice. The 
annealed probe-RNA mixture and probe-free RNA mixture were treated with 5 units of RNAse 
H in 1x RNase H buffer (New England Biolabs) for 30min at 30oC, followed by RNase H heat 
inactivation by incubating at 65oC for 20 min. cDNA was then generated from each sample using 
a 5HT2C gene specific primer (5’-CAATCACAGGGATAAGAACTGAAACTCCTATTG-3’) 
and the High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to 
manufacturer’s instructions. The cDNA was then amplified by PCR using OneTaq master mix 
(New England Biolabs) using the gene specific antisense primer used for reverse-transcription 
and one of two sense primers; either 5’ of the putative methylation site (5’-TATTTGTGCCCC-
GTCTGG-3’) or 3’ of the predicted cleavage site (5’-TTTCAATTCGCGGACTAAGGC-3’). 
Resulting PCR products were resolved on 2% agarose gels and 2’-O-methylation was quantified 
by ethidium bromide fluorescence of the 205 and 85 bp DNA fragments corresponding to 2’-O-
methylated and non-methylated RNAs, respectively.  
Receptor Binding  
To quantify 5HT2C receptor expression, saturation binding analyses was performed using  
frozen, powdered human tissues which were mechanically homogenized at 15000 rpm for 10 
seconds (s) (Tissue Tearor; Biospec Products) in 2 ml of standard binding buffer (SBB; 50mM 
Tris–HCl, pH 7.4, 10mM MgCl2, 0.1 mM EDTA) and then centrifuged at 25,000 x g for 10 min. 
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 The supernatant was removed and the pellet was resuspended in 1 ml of SBB and transferred to 
1.7 mL Eppendorf tubes. The tissue was then spun at 16,000 x g in a microcentrifuge for 5 min at 
4°C. The supernatant was removed and the tissue pellets were frozen at −80°C until used for 
binding experiments. Total binding was determined using N6-methyl-[3H]-mesulergine (8-point 
curves were generated using [3H]-mesulergine concentrations of 0.25, 0.5, 1.0, 1.5, 2.0, 4.0, 6.0, 
and 8.0 nM) with non-specific binding measured using those same concentrations of [3H]-
mesulergine plus 8 μM ritanserin; both sets of conditions included 100 nM spiperone to block 
5HT2A receptor binding. Bradford protein assays were performed to quantify protein in each 
pellet (BioRad Laboratories). All incubations were performed in SBB for 1.5 h at room 
temperature. Incubations were terminated by rapid filtration using Whatman GF/C glass fiber 
filters, washed 3 times with cold 50mM Tris–HCl (pH 6.9 at room temperature, pH 7.4 at 4 °C). 
Samples were measured by liquid scintillation spectrometry in a Perkin-Elmer Tri-Carb 2800TR 
counter and data were analyzed using GraphPad Prism (Graphpad Software; San Diego, CA) 
using nonlinear regression to fit the experimental data to saturation binding equations (assuming 
depletion). Maximal binding (Bmax) values were normalized to the protein concentration for each 
sample.  
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  Results 
Analysis of Genotype and Sample Integrity 
 Tissue samples from patients with Prader-Willi Syndrome were acquired from the 
NICHD Brain and Tissue Bank for Developmental Disorders (Baltimore, MD) where the 
disorder was identified based upon clinical presentation and physical diagnosis (Table 3). To 
verify that PWS patients had molecular deficits consistent with the diagnosis of this syndrome, 
genomic DNA from each patient was isolated and subjected to analysis using methylation-
specific multiplex ligation-dependent probe amplification to determine the integrity and 
methylation status of the PWS locus [101]. Results from this analysis revealed that two of the 
patients initially diagnosed with PWS contained neither deletions nor apparent methylation 
defects (patients 1556 and 4876; data not shown), suggesting alternative molecular 
mechanism(s) were contributing to the PWS-like phenotype in these individuals. A recent study 
using PWS samples from the NICHD Brain and Tissue Bank further confirmed that one of these 
patients (4876) expressed SNRPN, SNORD115, and SNORD116 transcripts which does not 
support a genetic diagnosis of Prader-Willi syndrome [104]. These non-PWS samples were 
excluded from further analysis, except where indicated. 
 The hippocampus is a C-shaped structure made of two rolled-up laminae, the cornu 
Ammonis (fields CA1, CA2/3) and the dentate gyrus. Its ventricular aspect is covered by the 
choroid plexus of the inferior horn, an ependymal tissue which plays an important role in the 
production of cerebrospinal fluid (CSF) and expresses very high levels of 5HT2C transcript and 
receptor protein relative to surrounding neuronal tissue [105, 106].  
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 Table 3. Summary of control and PWS brain samples for 
analysis of 5HT2C RNA and protein expression. All human 
tissue samples were obtained from the NICHD Brain and Tissue 
Bank for Developmental Disorders (Baltimore, MD). Diagnosis 
of PWS was based upon clinical analysis of phenotype and the 
age (years) at time of death and post-mortem interval (PMI; 
hours) are indicated. The availability of indicated brain regions 
from each patient is designated by a plus (+) or minus (-) sign. 
Ctx, cortex; Str, striatum, Hip, hippocampus. 
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 [107] [108]. Importantly, the 5HT2C editing profile in choroid plexus is significantly different 
from surrounding brain regions, where editing at the A and B sites is dramatically reduced [81], 
suggesting that small levels of choroid plexus contamination in the hippocampus samples could 
significantly affect 5HT2C editing profiles, complicating any interpretation of results. For this 
reason, we chose to exclude any tissue samples that contained high levels of choroid plexus 
contamination from further analysis. To determine the extent of choroid plexus contamination, 
we employed real-time RT-PCR to quantify human coagulation factor V (F5) mRNA, an RNA 
target that is highly enriched in choroid plexus, but absent from surrounding brain tissue [109]. 
Results from this analysis indicated that F5 mRNA expression was high in a majority of the 
hippocampus samples isolated from both control and PWS patients, varying by up to four orders 
of magnitude between samples. Comparisons between the extent of editing at the A and B sites 
for 5HT2C transcripts and F5 RNA levels showed a significant correlation (R2= 0.4884; p ≤ 
0.0002), indicating that choroid plexus contamination was a major driver of 5HT2C editing 
profiles in the acquired hippocampal RNAs (Figure 16A). However, only background levels of 
F5 mRNA were detected by qRT-PCR in any of the striatal or cortical tissue samples (data not 
shown). As an additional strategy, we also quantified the level of 5HT2C mRNA and receptor 
protein expression in hippocampus samples as markers of choroid plexus contamination, since 
previous studies have demonstrated that 5HT2C expression in the choroid plexus is higher than 
surrounding brain regions [105-108, 110]. Analyses of 5HT2C mRNA and receptor protein levels 
using qRT-PCR and saturation binding with [3H]-mesulergine, respectively, revealed a 
significant correlation between 5HT2C expression and F5 mRNA levels (Figure 16B, C), further 
supporting the hypothesis that hippocampal RNA editing profiles are strongly tied to choroid 
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 plexus contamination. For this reason, we excluded the analysis of hippocampal tissue for 
comparisons between patient groups. 
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Figure 16. Analysis of choroid plexus contamination in hippocampus samples. A) The extent of 
editing at the A-site for 5HT2C transcripts in each hippocampus sample (PWS and control) was 
compared to the relative mRNA expression for a choroid plexus marker, coagulation factor V (F5). 
The best-fit curve, determined by linear regression analysis, is indicated with a dashed line (R2= 
0.4884; p ≤ 0.0002). B) Correlation between relative 5HT2C and F5 mRNA expression (R2= 0.3561; p 
≤ 0.0034). C) Correlation between 5HT2C-specific total binding (Bmax) values and F5 mRNA 
expression (R2= 0.7042; p ≤ 0.0001).  
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 RNA expression and alternative splicing 
 Alternative splicing of 5HT2C pre-mRNAs can generate three distinct mRNA species 
from the use of different 5’-splice sites located in exon 5 and intron 5 (Figure 17). Use of the 
proximal and distal 5’-splice sites results in the generation of mRNAs encoding truncated non-
functional receptor, 5HT2C-tr (RNA1) [9], and 5HT2C-COOHΔ (RNA3) [81], respectively, 
whereas use of the intermediate splice junction generates RNA2 which encodes the full-length, 
functional 5HT2C receptor. Previous analyses of 5HT2C transcripts in mice sole expressing the 
VGV isoform of receptor revealed alterations in the alternative splicing pattern for 5HT2C pre-
mRNAs with an increase in the steady-state level of RNA2 and a corresponding decrease in 
RNA1 [24], consistent with observations that editing at the E, C and D sites promotes the pro-
duction of RNA2 at the expense of RNA1 [111]. Recent characterization of the receptor isoform 
encoded by RNA 1 has revealed that although this truncated gene product does not function as a 
G-protein coupled receptor, it can dimerize with the full length receptor protein (RNA 2 gene 
product) to retain receptor heterodimers in the endoplasmic reticulum [112]. RNA3 is rarely 
detected and the functional relevance of this transcript variant has not been examined. Previous 
reports have provided evidence that one of the snoRNAs encoded in the PWS locus SNORD115 
and its mouse homologue MBII-52 play a role in the regulation of pre-mRNA splicing of the 
5HT2C transcript [88]. These studies predict that SNORD115 promotes the formation of RNA2 at 
the expense of RNA1 by partially blocking a ‘splice silencer’ located within exon 5. Since PWS 
patients lack expression of SNORD115, it is anticipated that the relative expression of 5HT2C 
RNAs 1 and 2 would be increased and decreased, respectively, in PWS patients compared to 
normal controls.  
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  Relative 5HT2C RNA expression was determined by qRT-PCR using a Taqman probe 
which spanned the exon 3-4 splice junction to detect all three alternatively splice isoforms. These 
studies did not indicate a significant difference in steady-state 5HT2C mRNA levels between 
control and PWS patients (Figure 18). RNA expression was variable within each group, possibly 
reflecting a combination of factors including region-specific dynamic regulation in human 
populations. The high variability in mRNA expression was especially prominent in the striatum 
which could result from variations in spatial expression between striatal sub-regions. The steady-
state level of 5HT2C transcript expression in the cortex was very low compared that observed in 
the striatum, consistent with previous in situ hybridization analyses [105-108]. 
 Consistent with the model proposed by Kishore et al [88], analyses of alternative splicing 
revealed a significant reduction in RNA2 with a concomitant increase in RNA1 in tissue samples 
from PWS patients (Figure 19). Interestingly, we see an even greater reduction in the relative 
expression of RNA2 to RNA1 in the PWS-like patients who received a clinical diagnosis of 
PWS, but were not found to harbor a canonical genetic defect within the PWS locus. It is not 
clear how decreased expression of RNA2 is related to the phenotype, but the two PWS-like 
patients displayed pronounced cognitive and metabolic dysfunction resembling that typical of 
PWS. 
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Figure 17. Alternative splicing of 5HT2C transcripts. A) A scaled diagram of the human serotonin 
2C receptor gene (Htr2c), located at position 114584078-114910061 of the X chromosome, is 
presented; the sizes of exons and introns are indicated in base pairs (bp). B) Schematic diagram of 
three alternative splicing events in 5HT2C pre-mRNA to generate distinct, mature mRNAs (RNA1, 
RNA2 and RNA3). Sequences surrounding the alternative splice junctions are presented with a 
horizontal dashed line, the conserved GU at alternative 5’-splice sites is underlined, the position of the 
editing sites are indicated with small blue circles and the lengths of relevant exon and intron regions 
are presented in nucleotides (nt). C) Amino acid sequences encoded by alternatively spliced 5HT2C 
mRNAs. The predicted transmembrane-spanning domains are indicated in bold and the genomically-
encoded amino acids at the sites affected by RNA editing are shown in blue. Novel amino acids 
resulting from splicing to an alternate reading frame are indicated with red lettering. D) Predicted 
topology of 5HT2C receptors encoded by alternatively spliced mRNA variants. The amino acid 
residues affected by RNA editing are shown in blue and novel amino acids resulting from splicing to 
an alternate reading frame are indicated with red circles. 
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Figure 18. Quantitative analysis of relative 5HT2C mRNA expression. Relative 5HT2C mRNA 
expression levels from PWS and control brain regions were determined by quantitative RT-PCR; the 
mean value for each group is indicated with a horizontal bar. 
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 Figure 19. Quantitative analysis of the relative expression levels for 5HT2C alternative splicing 
variants. Expression of the major spliced isoforms of 5HT2C receptor mRNA were quantified by end-
point PCR from multiple brain regions isolated from control and PWS patients. Two individuals that 
were initially diagnosed with PWS based upon clinical evaluation, but lacked a detectable defect in the 
PWS locus (non-PWS), are also shown. Data are presented as the percentage of RNA2 transcripts 
relative to total 5HT2C mRNA expression; the mean value for each group is indicated with a horizontal 
bar and compared using Student’s t-test. 
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 Analysis of RNA Editing Profiles 
 To assess whether 5HT2C pre-mRNA editing is altered in PWS, we quantified RNA 
editing profiles using a high-throughput sequencing strategy as described in Chapter 1.  The data 
from these studies initially was compared by examining site-selective modification at each of the 
five editing sites (A, B, E, C and D) in RNA samples isolated from PWS and control patients 
(Figure 20). This analysis did not reveal any significant differences in the frequency of editing at 
any site for all brain regions analyzed. Since combinatorial patterns of editing can give rise to 32 
mRNA isoforms encoding 24 distinct receptor species, we also analyzed the data to examine 
potential changes in isoform expression at both the RNA (Figure 21) and protein (Figure 22) 
levels. A significant reduction in the percentage of transcripts encoding the VNV receptor 
isoform was observed in both the striatum and cortex (striatum p ≤ 0.01, cortex p ≤ 0.05) 
(Figures 21, 22). This transcript profile predicts that PWS patients express a decreased 
percentage of protein isoforms containing valine, asparagine and valine (VNV) at amino acid 
positions 156,158, and 160, respectively (Figure 1 and 22) . Interestingly, similar changes in 
editing profile have been reported for PWS-ICdel+/- mice, a construct valid mouse model of PWS 
[113]. While it is unlikely that such a small change could lead to the profound phenotype 
observed in PWS, it is important to note that observed difference in the 5HT2C editing profile for 
PWS patients could reflect a much larger change in discrete subpopulations of neurons. 
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 Figure 20. Quantitative analysis of site-selective 5HT2C editing observed in RNA samples isolated 
from the cortex and striatum of control (white) and PWS patients (blue). Error bars represent the 
mean ± SEM; n>12. No significant differences at any of the editing sites were observed using 
Student’s t-test. 
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Figure 21. Sequence analysis of brain region-specific 5HT2C RNA editing profiles. Editing profiles 
in dissected brain regions were determined by high-throughput sequence analysis and the thirty-two 
possible 5HT2C RNA isoforms resulting from RNA editing are represented as the percentage of total 
5HT2C sequence reads for control and PWS patients in each brain region. Means ± SEM were 
compared by two-way ANOVA; *p<0.05, **p<0.01. 
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Figure 22. Comparisons of the most common 5HT2C protein isoforms predicted by the RNA 
editing profile in controls and PWS patients. Predicted amino acids at the editing sites are shown 
with the single letter amino acid code for the major receptor isoforms and are represented as the 
predicted percentage of total 5HT2C receptors for control and PWS patients in each brain region. 
Means ± SEM were compared by Student’s t-test; *p<0.01, ***p<0.001. 
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 Analysis of 5HT2C Receptor Protein Density 
 Previous studies of mutant mice solely expressing the fully-edited (VGV) isoform of the 
5HT2C receptor revealed a number of phenotypic alterations similar to those observed in patients 
diagnosed with PWS. In addition, a number of molecular alterations also were identified in 
mutant animals including a dramatic increase in 5HT2C receptor density, despite any observed 
differences in steady-state 5HT2C mRNA levels [24]. The mechanistic explanation for this 
phenotype is currently under investigation, but may result from differences in translation 
efficiency or constitutive activity-dependent alterations in subcellular localization that could 
affect receptor isoform stability [114]. A saturation binding strategy was employed to quantify 
the receptor density for protein samples isolated from the striatum and cortex of PWS and 
control patients. No specific binding was detected in cortex samples, consistent with the low-
level of steady-state 5HT2C mRNA expression previously observed in this brain region (Figure 
17). In the striatum however, 5HT2C receptor density in PWS samples was two-fold greater than 
that observed in control patients (p ≤ 0.01) (Figure 23). Considerable inter-individual variation 
also was observed for receptor density in the striatum, similar to the variability identified in 
analyses of 5HT2C mRNA levels (Figure 16).  
Analysis of 2’-O-methylation 
 SNORD115, and its mouse orthologue (MBII-52), are members of the box C/D family of 
snoRNAs that are responsible for directing the 2’-O-methylation of specific ribose moieties in 
pre-ribosomal RNA transcripts and U small nuclear RNAs [115]. SNORD115 is complementary 
to an 18 nucleotide segment of 5HT2C mRNA containing three of five editing sites (E, C and D), 
predicting 2’-O-methylation of the ribose for the adenosine at the C-site [100], 
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Figure 23. Quantitative analysis of 5HT2C-specific binding. Saturation binding isotherms were used 
to determine 5HT2C receptor density in total membranes prepared from brain regions isolated from 
control and PWS patients; the mean value for each group is indicated with a horizontal bar and 
compared using Student’s t-test. 
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 an editing position that determines the identity of amino acid 159 for the 5HT2C receptor and sig-
nificantly affects the function of encoded protein isoforms [29, 34]. Previous studies using syn-
thetic RNAs have indicated that ribose 2’-O-methylation leads to a >200-fold decrease in the rate 
of editing for the modified adenosine nucleoside suggesting that this snoRNA, which is absent in 
PWS, may serve to inhibit A-to-I conversion at the edited C-site. Several attempts to detect 2’-O-
methylation at this site using a reverse transcriptase-dependent primer-extension strategy have 
been unsuccessful, presumably due to insufficient sensitivity for this experimental approach [30]. 
To increase the sensitivity of 2’-O-methylation detection, we used an RT-PCR-based approach, 
as previously described by Yu et al [103]. In this paradigm, the extent of site-specific 2’-O-
methylation is quantified using an RNA-DNA chimeric probe to direct ribonuclease (RNase) H 
cleavage at the modified nucleoside. RNAse H cleavage is inhibited in the presence of 2’-O-
methylation, allowing RT-PCR amplification of cleaved and uncleaved RNA templates (Figure 
24A). Because site-selective 2’-O-methylation requires precise complementarity between the 
hybrid probe and mRNA target, it was not impossible to directly assess methylation of human 
5HT2C mRNAs due to the presence of multiple nucleoside alterations resulting from RNA 
editing events within the region of the probe. As an alternative approach, we assessed 
methylation of 5HT2C transcripts in RNA isolated from whole brains of mutant mice engineered 
to express only the non-edited (INI) isoform of the 5HT2C receptor. This allowed the design of a 
chimeric probe for a single edited isoform that selectively targeted RNAse H to detect 2’-O-
methylation of the ribose for the adenosine at the C-site. Use of this approach with 5’-end 
labeled, synthetic RNAs (31 nt), with and without a 2’-O-methyl modification, generated RT-
PCR amplicons of the expected size that displayed a low level of incomplete digestion for the 
unmodified target (Figure 24B). Parallel analyses with mutant mouse RNA, revealed efficient 
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 amplification of the cleaved RT-PCR product (85 bp), but only background levels of the non-
cleaved product (205 bp) were observed in the presence of the chimeric probe, indicating no 
detectable 2’-O-methylation (Figure 24C) at steady-state. However, this assay cannot rule out the 
possibility that transient methylation events may occur in the pre-mRNA which could impact 
splicing or inhibit the efficiency of editing at the C site. 
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Figure 24. Analysis of site-selective 2’-O-methylation in 5HT2C transcripts. A) Schematic diagram 
depicting an experimental strategy to detect 2’-O-methylation in 5HT2C transcripts using a hybrid 
DNA/RNA oligonucleotide probe. A portion of the 5HT2C mRNA is shown with the predicted position 
of SNORD115-mediated 2’-O-methylation (-OCH3), as well as the hybrid DNA/RNA oligonucleotide 
probe designed to direct RNAse H-mediated cleavage in non-modified 5HT2C transcripts; RNA 
residues are indicated in red and DNA residues are indicated in black. After incubation with RNase H, 
RT-PCR amplification of RNAs corresponding to cleaved (non-modified) and non-cleaved (2’-O-
methylated) forms of 5HT2C transcripts were amplified with sense primers located up- and 
downstream from the predicted cleavage site and a single antisense primer (bold arrows), giving rise to 
PCR amplicons of 205 and 85 bp. B) 2’-O-methylation analysis of synthetic 5HT2C RNA standards 
(31 nt) corresponding to non-modified and 2’-O-methylated transcripts were digested with RNase H in 
the presence of the hybrid DNA/RNA oligonucleotide probe and the reaction products were resolved 
by denaturing polyacrylamide gel electrophoresis to generated the expected 31 and 11 nucleotide 
products. C) 2’-O-methylation analysis of whole brain RNA isolated from mutant mice solely 
expressing the non-edited (INI) isoform of the 5HT2C receptor. Representative data from two animals 
is shown where the expected migration positions for the RT-PCR products derived from 2’-O-
methylated (85 bp) and non-modified (205 bp) 5HT2C transcripts are presented. 
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 Discussion 
Previous studies have shown that the maternally imprinted snoRNA, SNORD115, can 
alter both the splicing and editing of 5HT2C transcripts in a heterologous expression system [88], 
providing a provoking and straightforward mechanism by which to link the 5HT2C gene 
expression with the Prader-Willi locus on chromosome 15q11-13. These observations are 
consistent with analyses indicating that 5HT2C RNA editing is increased in autopsy samples from 
PWS patients [88] and a mouse model (PWS-ICdel) that also demonstrates alterations in 5HT2C-
related behaviors including reactivity to palatable foodstuffs and impulsivity [116]. In the present 
study, 5HT2C RNA editing was minimally affected by PWS diagnosis, although the possibility 
that this RNA modification is differentially regulated in other brain regions or specific cell types 
cannot be ruled out. However, a significant reduction in transcripts encoding the VNV isoform of 
the receptor and an increase in transcripts encoding the VSV isoform (Figure 22) was observed. 
These findings are consistent with previous analyses of PWS ICdel+/- mice which also showed an 
increase in VSV-encoding transcripts [113]. Interestingly, these differences primarily result from 
changes in editing at the C site, the adenosine predicted to be targeted for 2’-O-methlyation by 
SNORD115 [100]. 
Previous studies have shown that 2’-O-methylation dramatically reduces the efficiency of 
ADAR-mediated deamination [117, 118], yet stable methylation of the ribose at the C site in 
5HT2C mRNAs from mutant mice could not be detected. Several clinical cases have been 
identified that either suggest deletion of SNORD115 is not sufficient to cause a PWS-like 
phenotype [119] or that a specific paternal deletion of the SNORD116 (HBII-85) snoRNA 
cluster can result in PWS [120-122]. While most recent clinical and mouse studies have focused 
upon the SNORD116 snoRNA cluster as playing a causal role in PWS [95, 96, 119-121], the 
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 targets of these imprinted snoRNAs remain largely unknown, raising the possibility that 
alternative mechanisms exist by which genes located within the 15q11-13 locus can alter 5HT2C 
receptor function independent of SNORD115 expression. 
The role of SNORD115 is not well understood, and several reports suggest disparate 
models related to its function and biology [123-125]. Studies in heterologous systems have 
provided evidence that it not only affects the splicing of 5HT2C transcripts, but also the splicing 
of other pre-mRNA transcripts [123]. The present studies suggest that SNORD115 promotes the 
production of RNA2 at the expense of RNA1. In support of these hypotheses, reduced RNA2 
and increased RNA1 levels were observed in RNA samples from PWS patients lacking 
SNORD115. The functional consequences of increased expression for the truncated RNA1 gene 
product have been examined recently to show that this alternatively spliced isoform may serve to 
decrease the accumulation of functional 5HT2C receptors at the cell surface [112] by nuclear 
retention of heterodimers in the endoplasmic reticulum. Reductions in surface expression are 
predicted to reduce 5HT2C signaling in POMC neurons, thereby increasing food consumption by 
decreasing the anorexigenic effects of serotonin, consistent with the hyperphagia observed in 
PWS. 
Although limited to a single brain region, analysis of receptor density in the striatum of 
PWS patients demonstrated a nearly two-fold increase, with no concomitant increase in steady-
state mRNA levels (Figures 18, 23). By contrast, mutant solely expressing the fully-edited 
(VGV) isoform of the 5HT2C receptor displayed a 40-70-fold increase in receptor protein [24, 
112]. It is not clear how increased 5HT2C receptor density may contribute to the etiology of 
PWS, yet it appears to be a common feature for PWS patients and mutant VGV mice which 
phenocopy many aspects of this disorder [24]. While the magnitude of these differences cannot 
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 be compared directly, it should be noted that such differences could result from alterations in 
basal 5HT2C signaling. The major 5HT2C RNA isoforms expressed in mouse and human brains 
encode the VNV and VSV isoforms of the receptor, respectively (Figures 21 and 22), displaying 
significantly different signaling properties relating to G-protein coupling and constitutive 
activity. 
The present studies have shown changes in 5HT2C alternative splicing (Figure 18), RNA 
editing (Figure 21) and receptor density (Figure 23) for RNA samples isolated from dissected 
brain regions of PWS patients compared to controls, indicating that genes within the PWS locus 
either directly or indirectly modulate 5HT2C expression. Observations that mutant mouse models 
of this disorder share aspects of altered 5HT2C expression [113] and changes in 5HT2C-mediated 
behavior [87], as well as studies indicating that introduction of editing alterations in mutant mice 
can phenocopy several aspects of PWS [24] further supports a relationship between 5HT2C 
receptor expression and the Prader-Willi critical region. Given the complex relationship between 
editing, splicing and receptor density observed in VGV mutant mice [24], it is not surprising that 
changes in all three aspects of 5HT2C expression also were observed in PWS patients. Although 
multiple mouse models lacking expression of one or more PWS candidate genes have implicated 
several loci with aspects of the PWS phenotype, these models vary widely in their capacity to 
recapitulate the human disorder [93-96, 126], suggesting that individual genes or gene 
combinations may be responsible for only a subset of syndrome phenotypes. The 5HT2C receptor 
has been implicated directly in the anorectic modulation of food intake using both genetic 
models and pharmacological approaches [43, 48, 50], thereby making it a promising target for 
therapeutic intervention in Prader-Willi Syndrome. 
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 Chapter IV 
COMPARATIVE ANALYSIS OF A-TO-I EDITING IN HUMAN AND NON-HUMAN 
PRIMATE BRAINS 
5HT2C editing profiles in humans and non-human primates 
 One of the most interesting observations made while analyzing 5HT2C editing profiles in 
human tissue samples was the remarkable variability observed between individuals. This 
contrasts with observations in rodents reared in a laboratory setting that display near identical 
editing profiles regardless of experimental exposure (Chapter 1) [51, 127]. The observed 
variability in the human population provides an opportunity to investigate the interrelatedness of 
site-selective editing for different transcripts across development, as well in discrete anatomical 
regions. It is fascinating to consider the prospect that these inter-individual differences result 
from active processes regulating A-to-I conversion and that editing could be dynamically-tuned 
throughout life to provide physiological advantage. Alternatively, differences in editing between 
transcripts and brain regions could be relatively stochastic, dictated by a molecular balance 
encoded by the genomic differences represented by this cohort of individuals. In an effort to 
differentiate between these possibilities, we examined editing profiles for several editing targets 
in human brain samples and compared them to equivalent RNA samples isolated from the 
Rhesus macaque (Macaca mulatta) raised in a controlled laboratory environment in hopes of 
better discriminating the effects of environment and genetics on A-to-I editing.     
In addition to 5HT2C RNAs, numerous additional transcripts in the nervous system are 
modified by A-to-I editing to introduce non-synonymous amino acid alterations that affect 
protein function. For these studies, we selected several of these editing sites for further analysis 
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 including: 1) the Q607R editing site on transcripts encoding the GluR-2 subunit of the AMPA-
subtype of ionotropic glutamate receptor [128]; 2) the R/G site of transcripts encoding the GluR-
4 subunit of the AMPA receptor [129-130]; 3) the Q124R site on transcripts encoding type 4-
metabotropic glutamate receptor (mGluR4) (Chapter 2); 4) the I342V site on transcript encoding 
the α3-subunit of the ionotropic γ-amino butyric acid receptor (GABRA3) [131]; and 5) the 
E1250G site in transcripts encoding Ca2+-dependent activator protein for secretion (CAPS1) 
[132]. Each of these substrates is widely expressed throughout the brain and encodes a protein 
critical for nervous system function including components of the synaptic signaling machinery 
ranging from pre-synaptic modulation (mGluR4), postsynaptic inhibition (GABRA3) and 
postsynaptic excitation (GluR2/4), to vesicle fusion and release (CAPS1). The functional 
consequences resulting from editing-dependent amino acid alterations for some of these RNAs 
have been well characterized [16, 19, 29, 34, 131] while others are the subjects of ongoing 
research. To probe the interrelationship of RNA editing at multiple sites from dissected brain 
regions in two primate species, simultaneous quantification of RNA editing profiles may be 
performed in each RNA sample, enabling us to gain mechanistic insights from patterns of editing 
within individuals and across brain regions. We carried out these studies by measuring the extent 
of editing for each of these seven substrate transcripts in matched hippocampus, striatum, and 
frontal cortex across the human cohort used in the PWS studies in addition to a cohort of 12 
rhesus macaques.    
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 Methods 
Quantitative analysis of editing profiles 
 The human RNA samples analyzed for these studies are the same PWS and control 
samples analyzed in Chapter III. Primers designed to amplify each respective editing site of 
interest were used in the initial five cycles of RT-PCR amplification as described for 5HT2C 
transcripts in Chapter II. For this study, primers were designed to selectively amplify the edited 
region of the transcripts encoded by the following genes: GABRA3, GRM4, GRIA2, GRIA4, 
and CADPS. Due to unique sequences resulting from alternative exon inclusion, we also could 
discriminate between the alternatively spliced GRIA4-Flip and GRIA4-Flop isoforms providing 
additional information about potential relationships between splicing and editing. 
 RNA editing profiles were quantified using next-generation sequencing as schematized in 
Figure 2 [102]. Amplified products for each RNA target were pooled, separated in a 2% agarose 
gel and purified from excised gel slices using the Wizard SV Gel and PCR Purification Kit (Pro-
mega). The concentration of gel-purified fragments was determined by spectrophotometry (A260) 
and ~20 ng of each sample was pooled with up to 24 other products containing unique barcodes 
and subjected to single-end sequencing using the MiSeq platform (Illumina). 
Informatics 
 The FASTX-Toolkit was used to resolve the sequencing reads according to each of 24 
different barcodes incorporated during the second round of PCR amplification [102]. For each 
read, pairwise alignments were made against all reference sequences allowing for only one A-to-
G mismatch at the editing site and assigned to match its corresponding candidate gene. The 
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 extent of editing at each site was calculated as the percentage of edited (G) reads for each 
substrate divided by the total number of reads (G + A) for each target. 
Statistical Analysis 
 Analysis of covariance was performed by quantifying the extent of site-selective editing 
by the patient diagnosis, age, sex, and PMI. Correlations were analyzed for statistical 
significance using Student’s t-test for disease diagnosis and gender or linear regression analysis 
for continuous variables including ADAR expression, age and PMI. No significant effect was 
identified for any of these variables. Linear regression was also used to compare the extent of 
editing in different brain regions and the extent of editing for different substrates.  
Quantification of ADAR mRNA expression 
Substrate-specific Taqman probes and primer sets were selected to detect steady-state 
mRNA expression levels for ADAR1 (Hs00241666_m1 and Rh02801420_m1) and ADAR2 
(Hs00953724_m1 Rh00955199_m1) (Applied Biosystems). Real-time RT-PCR was performed 
as described in Chapter 2 and ∆∆Ct values were determined by comparing cycle threshold for 
each ADAR transcript to an 18S ribosomal RNA internal control (4319413E).  
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 Results 
Covariant analysis of CADPS, GluR2, GluR4, GABRA3, and mGluR4  
 We quantified the extent of editing for several substrates by high-throughput sequence 
analysis in matched hippocampus, striatum, and frontal cortex samples from both humans and 
Rhesus macaques. After data collection, we performed analyses of covariance indicating that 
gender, age, postmortem interval or PWS diagnosis did not differentially affect editing profiles. 
None of these factors appear to correlate with the extent of editing for any of these substrates in 
the brain regions analyzed (ANCOVA, p ≥ 0.05).  
Differential regulation of A-to-I editing in different substrates 
Previous studies have demonstrated characteristic editing profiles in facility-housed 
inbred rodents for specific ADAR targets within dissected brain regions [51, 64, 133], yet the 
extent of editing can vary widely between different RNA targets within the same brain region, 
For example the transcript encoding the GluR-2 subunit of the AMPA-subtype of glutamate 
receptor (GRIA2), is edited nearly 100% of the time in rodents (Q/R site), while other ADAR2 
substrates such as the D site in 5HT2C transcripts is edited only ~60% of the time [51, 64, 133]. 
Similarly, another ADAR2 substrate, the mRNA encoding the type-4 metabotropic glutamate 
receptor (GRM4), is edited around 10-15% in most tissues analyzed (Figure 25). Such 
dissimilarities in editing could be explained by cell-specific differences in the expression/activity 
of ADAR proteins, but not for ADAR targets expressed within the same neuron. An alternative 
interpretation of these observations is that RNA substrates have unique intrinsic propensities to 
undergo hydrolytic deamination and are therefore autonomously regulated by differential affinity 
and/or availability. By simultaneously monitoring the editing efficiency of multiple substrates 
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 across diverse populations of individuals, we can make inferences about the co-regulation of 
substrates across brain regions and learn more about the nature of how A-to-I editing is regulated 
on a substrate-to-substrate basis. 
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Figure 25. Quantitative analysis of editing efficiency for ADAR targets in samples isolated from 
the striatum, cortex, and hippocampus of humans and macaques. A) The extent of site-selective 
editing is shown for RNA samples isolated from the macaque putamen, motor cortex, and 
hippocampus. (n=12). Error bars represent the mean ± SEM; *p ≤ 0.01, **p ≤ 0.001. B) The extent of 
site-selective editing is shown for RNA samples isolated from human striatum (blue), cortex (red), and 
hippocampus (green). (n=28).  
94 
 
 Overall patterns of editing in the brain 
 Editing was quantified for multiple RNA substrates in dissected brain regions isolated 
from human and macaque cohorts. The values for 5HT2C editing profiles in three and eight 
hippocampal samples isolated from macaque and human brain, respectively, was excluded from 
the dataset due to choroid plexus contamination as described in Chapter III (Figure 16). The 
mean extent of editing observed at each respective substrate in these two species was generally 
similar, however considerably more variability was observed in the human population compared 
to the macaque cohort for each substrate (Figures 25 and 26). Several editing patterns emerged 
that appeared to be highly conserved in both rhesus macaques and humans. In both species, the 
extent of GluR4-Flip, mGluR4, and GABRA3 editing was significantly higher in the cortex then 
either the striatum or hippocampus (2-way ANOVA, p ≤ 0.01). Editing patterns for GluR4-Flip, 
Gabra3, and CADPS were conserved across species, while editing in the cortex was significantly 
higher for GluR4-Flip and GABRA3, while CADPS editing was significantly lower in cortical 
tissue. Importantly, the extensive variability in editing observed in the RNA samples isolated 
from the human cohort was largely driven by a few individuals who displayed profound 
deficiencies in editing at a few, or in some cases all, of the substrates analyzed. In both species, 
the greatest variability in editing was observed for transcripts encoding the α3-subunit of the 
GABA receptor (GABRA3).  While site-selective editing patterns were found to be similar in 
humans and macaques, editing for GluR4-Flip and mGluR4 RNAs was much higher and lower, 
respectively, in all three brain regions of the macaque compared to corresponding human 
samples (Figure 26). These results suggest an evolutionary divergence in site-selective editing 
patterns, yet the functional significance of these findings is difficult to interpret due to a limited 
understanding concerning the precise role(s) played by these edited isoforms in vivo.  
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Figure 26. Quantitative analysis 
of region-specific, site-selective 
RNA editing patterns in human 
(■) and macaque (■) brain. The 
percentage of editing for site-
selective modification of ADAR 
targets in dissected brain regions is 
shown; SEM values for the human 
(red) and macaque (black) cohort 
for each transcript are provided 
(human n=28, macaque, n=12). 
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 Conversely, another pattern observed in both species was that CADPS editing was 
significantly lower in the cortex than in hippocampus or striatum (p ≤ 0.01) (Figure 25). These 
results show that although editing is regulated in a region-specific manner in the brain, this 
pattern of RNA modification is conserved between humans and macaques. The fact that 
evolution has retained these patterns across primate species suggests that the extent of editing for 
these substrates is important for conferring evolutionary fitness.  
Co-regulation of RNA editing  
When profiling editing patterns in the human cohort, a higher level of variability was 
observed than previously identified for other species (Chapter 1). This variability was largely 
driven by a few individuals with large deficiencies in editing at specific substrates, or in some 
cases, a deficiency in editing for all mRNAs examined. We took advantage of this variation to 
examine potential co-regulation of editing across substrates and brain regions.                             
 As observed previously, editing at each of the five sites for 5HT2C transcripts was highly 
co-regulated [134], where the extent of editing at any one site generally predicted editing 
efficiencies at the other sites. These observations suggested an interdependence of editing within 
5HT2C mRNAs that may result from cooperation or a common rate-limiting step that controls 
editing at each of the five sites. This finding is not surprising considering that each of the 5HT2C 
editing sites is located in close proximity within the same RNA substrate. Similar correlations 
between the editing of 5HT2C transcripts and GABRA3 RNAs were also identified, specifically 
in the cortex (Pearson correlation p ≤ 0.0001, r2 = 0.8) (Figures 27 and 28). This relationship was 
not  
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 Figure 27: Correlational analysis of 5HT2C editing patterns across human brain regions. Pair-
wise comparisons of the percentage of site-selective editing for 5HT2C transcripts across human brain 
regions is presented; p ≤ 0.02, r2 ≥ 0.39 for each site by linear regression analysis. 
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Figure 28. Correlational analysis of RNA editing patterns across human brain regions. Pair-wise 
comparisons of the percentage of site-selective editing for several ADAR substrates across human 
brain regions is presented; Linear regression analysis identified significant correlations for GABRA3 
editing in the striatum and cortex, and mGluR4 in striatum and hippocampus (p ≤ 0.01, r2 ≥ 0.4; 
highlighted in red). 
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Figure 29: Correlational analysis of 5HT2C editing patterns across macaque brain regions. Pair-
wise comparisons of the percentage of site-selective editing for 5HT2C transcripts across macaque 
brain regions is presented. 
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 Figure 30. Correlational analysis of RNA editing patterns across macaque brain regions. Pair-
wise comparisons of the percentage of site-selective editing for several ADAR substrates across 
macaque brain regions is presented; Linear regression analysis identified significant correlations for 
CADPS editing in striatum and cortex, and GABRA3 editing in cortex and hippocampus (p ≤ 0.05, r2 
≥ 0.3).  
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 observed in striatum or hippocampus, despite similar levels of variability suggesting that the 
mechanisms or cell types regulating editing for these substrates are similar in cortex, but distinct 
in the hippocampus and striatum. This result implies that the stochastic events conferring 
variability in RNA editing for these two substrates may be similar in cerebral cortex. 
Another interesting relationship was the direct correlation observed for editing of GluR4-
Flip and GluR4-Flop transcripts. The extent of editing at GluR4-Flip turned out to be a strong 
predictor of the extent of editing at GluR4-Flop transcripts, specifically in the cortex (Pearson 
correlation p ≤ 0.001, r2 = 0.62). This finding could be related to the fact that these transcripts are 
generated by alternative splicing of the same pre-mRNA, and thus are subject to similar 
regulatory mechanisms. This effect was not observed in hippocampus or striatum further 
supporting the hypothesis that region- or cell-specific processes regulate A-to-I RNA editing for 
certain substrate RNAs.  
The finding that editing patterns for some substrates show significant correlations within 
specific brain regions, but not in others, could be explained by differences in the co-expression 
of these transcripts within the same cells in those respective brain areas. Detailed 
characterization of the co-expression profiles for these transcripts would be required to determine 
whether these relationships are driven primarily by cellular context or by substrate-specific 
mechanisms. While not mutually exclusive, these two possibilities carry unique implications 
regarding the mechanisms regulating editing. It would be interesting to test the hypothesis that 
editing for one ADAR2 substrate could be increased while editing of another ADAR2 substrate 
would be decreased in the same cell. Unfortunately, the difficulty of single-cell transcript 
analysis in postmortem human tissue precludes direct assessment of this model.  
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 Global regulation of editing across brain regions 
The variability in site-selective editing observed in the human cohort also has allowed us 
to address the hypothesis that editing for some substrates is regulated globally across different 
brain regions. We examined whether editing in one brain region could accurately predict the 
editing patterns in another brain region within the same individual. An analysis of co-
dependency was performed for site-selective editing for each substrate across brain regions by 
linear regression analysis and we considered any regression with a non-zero slope (p ≤ 0.01 and 
an r2 ≥ 0.4) sufficient to support the hypothesis that similar mechanisms may be actively 
regulating editing of the substrate in discrete brain regions. Editing of 5HT2C receptor transcripts 
appears to be uniquely co-regulated in the cortex and striatum as determined by linear regression 
analysis (Pearson correlation p ≤ 0.0001, r2 ≥ 0.5 for each site) (Figure 27). We also observed 
evidence for co-regulation of editing at GABRA3 transcripts in cortex and striatum (p ≤ 0.005, 
r2= 0.42), albeit to a lesser extent than observed for 5HT2C editing. These results indicate that the 
editing of 5HT2C and GABRA3 transcripts may be globally regulated by similar mechanisms in 
these two brain regions.  
We also observed a significant correlation for GRIA2 editing patterns across brain 
regions (Figure 28), but these results are difficult to interpret due to the limited range; as ~98-
99% of the transcripts were edited in all tissues from all individuals with the exception of a 
single patient (#1199). This individual had the lowest levels of GRIA2 editing in both striatum 
and cortex, implying some primary deficiency in editing for this substrate. Unfortunately, 
hippocampal tissue was not available from this patient, so we were unable to confirm this finding 
in a third brain region. Attempts to reproduce these findings in the rhesus macaque cohort were 
precluded by the relatively low levels of inter-animal variability (Figure 26). Despite significant  
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Figure 31. Pair-wise correlational analysis of editing patterns for multiple ADAR substrates in 
human cortex. A) GABRA3 editing directly correlates with 5HT2C editing in the cortex (A site 
shown, p ≤ 0.0001 r2 = 0.8) B) The editing of GluR4-Flip and GluR4-Flop RNAs correlate in the 
cortex (p ≤ 0.0001 r2 = 0.62), but not in the hippocampus or striatum. 
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genetic diversity in this region. Attempts to reproduce these findings in the rhesus macaque 
cohort were precluded by the relatively low levels of inter-animal variability. Despite significant 
genetic diversity in this population (Dr. Judy Cameron, personal communication), editing 
patterns varied little between individuals. These animals were raised in a highly-controlled 
environment, compared to the diverse environments experienced by individuals in the human 
cohort. These observations support the notion that environmental factors may influence the 
extent of editing in humans, although we cannot rule out contributions of genetic diversity.  
Analysis of RNA editing patterns in the Rhesus macaque 
 The Rhesus macaque (Macaca mullata) is a valuable model organism for biomedical 
research and one of the best studied non-human primates. Relatively few studies have 
investigated RNA editing in primates, so little is known about the relative conservation of editing 
patterns between macaques and humans. Detailed analysis of RNA editing in rhesus monkeys 
can provide insights related to the genetic contribution to editing profile that are precluded in 
inbred rodent lines with limited genetic diversity. We obtained matched RNA samples extracted 
from motor cortex, putamen, and hippocampus from 12 rhesus macaques and performed high-
throughput sequence analysis for the same set of substrates analyzed in human tissue samples: 
5HT2C, GluR-2, GluR-4, mGluR4, GABRA3, and CADPS. The animals used in this study were 
ovariectomized adult females classified as either control (n=6) or hypoactive (80% physical 
activity, n=6) by continuous monitoring using an accelerometer [135]. Covariant analysis did not 
reveal any effect of physical activity on editing profiles (data not shown). As mentioned 
previously, extensive conservation of editing patterns were found between individual animals, as 
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 well as some similarity to the patterns observed in humans. The major difference that was readily 
observed involved the extent of intra-individual variability (as measured by standard deviation 
from the mean) which was generally much less than that observed in the human cohort (Figure 
26). Making comparisons between macaques raised in a highly controlled environment and 
humans living under diverse circumstances allows us to infer the effect of environment on 
relevant variables. The similarity in editing patterns observed in macaques compared to variable 
patterns in the human cohort supports the idea that site-selective editing may be dynamically 
influenced by the environment.  
ADAR expression and editing profiles 
To test the hypothesis that site-selective editing patterns are simply regulated by ADAR 
expression, we measured steady-state mRNA expression levels for ADAR1 and ADAR2 in each 
tissue sample by quantitative RT-PCR. ADAR expression levels were highly variable between 
individuals and brain regions and no significant correlations were observed between site-
selective editing patterns and either the level of ADAR mRNA expression or the 
ADAR1:ADAR2 ratio for any of the substrates included in these studies. These results suggest 
that ADAR mRNA expression does not play a primary role in regulating editing patterns in vivo, 
although the level of ADAR protein or ADAR activity in each tissue sample represents a 
superior variable for comparison. The results of these studies did reveal a surprising relationship 
between mRNA expression levels for ADAR1 and ADAR2 (Figure 32) where a significant 
correlation was observed between the ratio of ADAR1 to ADAR2 that varied significantly 
between brain regions. Interestingly, these fixed ratios for ADAR1:ADAR2 mRNA expression 
appear to be largely conserved in humans and Rhesus macaques. 
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 Figure 32. Region-specific ADAR1 and ADAR2 expression in human and rhesus 
macaque brain. A) The mean ADAR1:ADAR2 ratio in each brain region is shown; and 
no significant differences were observed between species. Asterisks represent significant 
differences between mean combined ratios of both species in each brain region as 
determined by 1-way ANOVA with Bonferroni post-test (*p ≤ 0.01, **p ≤ 0.001).  B) 
Linear regression analysis of ADAR1 and ADAR2 expression in rhesus macaque reveals a 
significant correlation between ADAR expression in cortex (p ≤ 0.0001, r2 = 0.93) and 
hippocampus (p ≤ 0.0001, r2 = 0.92). C) Linear regression analysis of ADAR1 and 
ADAR2 expression in human reveals a significant correlation between ADAR expression 
in cortex (p<.0001, r2 = 0.91), striatum (p≤.0001, r2=.72), and hippocampus (p≤.0004, r2 = 
0.62). 
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 Discussion 
 One of the most interesting observations made while analyzing A-to-I editing in human 
brain tissue samples was the remarkable inter-individual variability. This contrasts with the 
observations made in rodents reared in a laboratory setting which display similar editing profiles 
regardless of experimental exposure. The variability in this human cohort provides an 
opportunity to examine the hypotheses that either environment or genetics are capable of 
influencing the profile of edited RNA isoforms expressed. An exciting prospect to consider is 
one where the processes regulating editing can be dynamically tuned throughout life in response 
to altering physiological cues. Alternatively, the observed differences could be stochastic and 
dictated by a molecular balance coded in the diverse genomes undoubtedly represented by this 
cohort of individuals. In an effort to differentiate between these models, we quantified editing 
profiles for several ADAR substrates in matched brain samples across brain regions in human 
populations. Additionally, we assessed editing in non-human primates raised in a controlled 
laboratory environment to better discern the effects of environment and genetics. 
 The results of these studies indicate that there are global mechanisms responsible for 
regulating editing for each of these substrates. This is clearly demonstrated in cases for certain 
individuals with global deficiencies in A-to-I editing that are seen across both ADAR substrates 
and brain regions. Conversely, several examples of context-specific regulation of editing also 
were observed, as some individuals demonstrated deficiencies in site-selective editing for only a 
few substrates in specific brain regions. Taken together, these results imply that several distinct 
levels of regulation exist which can affect the efficiency of editing either globally or can be 
limited to specific contexts.   
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 These studies clearly show that evolution has conserved mechanisms for maintaining 
precise site-specific editing profiles for ADAR targets across brain regions in adult mammals. 
Divergent patterns observed in some human individuals suggest that while editing often falls 
within characteristic ranges, it can vary widely. The fact that evolution has conserved editing 
patterns within specific ranges across species, suggests that the differences in editing observed 
for some human individuals are likely to have subsequent consequences for CNS function [136]. 
It will be important to identify the neurological consequences of altered editing profiles by 
studying larger human cohorts with detailed psychiatric and neurological histories. These further 
studies, in large human populations, will also facilitate discovery of gene-environment 
interactions and factors driving certain “abnormal” RNA editing profiles. Identification of factors 
capable of influencing site-specific editing profiles will be essential for building a more complete 
models of CNS function and potentially even exploited for therapeutic purposes. 
109 
 
 Chapter V 
CONCLUSIONS 
Through the course of these studies a number of insights have been revealed about the 
nature of A-to-I editing in the CNS. It is apparently a process under tight control in specific brain 
regions. Unfortunately, failure to induce alterations in editing profiles in response to genetic or 
pharmacological manipulation in vivo precludes a more detailed interrogation of the precise 
mechanisms conferring dynamic regulation. However, some of the results of this work lend 
themselves to the development of new models related to how editing might be regulated. A 
primary observation is that some substrates are edited nearly 100% of the time while others vary 
widely. Presumably, many of these transcripts are expressed in overlapping cell populations. 
These observations indicate that substrate-specific factors play a role in the regulation of A-to-I 
conversion. These differences could result from differences in ADAR activity, or due to the 
intrinsic affinity of specific substrates for the editing machinery, rendering ADAR availability 
rate-limiting in some cases and not in others. A third model involves substrate competition 
model where substrates compete for and potentially even chelate ADARs in relevant contexts: A 
number of transposable elements, including Alu elements in primates, are excellent non-protein 
coding substrates for ADARs [137]. Alu-rich RNAs and could potentially be employed to lure 
ADARs away from functional substrates effectively regulating the pool of active enzymes 
available. This is an attractive model but its contribution in vivo is currently only a matter of 
speculation. Additional layers of complexity emerge when considering the effects of editing on 
the function of particular gene products. Rather than a bimodal process where a substrate’s 
function is tuned in one direction or the other by RNA editing, proteins function as multimeric 
complexes that can consist of subunits encoded by both edited and non-edited transcripts.    
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 This complexity is especially evident in the case of 5HT2C, the gene products of which 
appear to function as dimers [138]. An editing-heterodimerization model provides an opportunity 
to express over 500 unique receptor complexes. Although, based on the RNA profiles observed 
in most tissues, combinations between the most common 4 or 5 isoforms would be expected to 
predominate. Recent studies even suggest that the incorporation of certain edited isoforms into 
dimeric complexes could be regulated in-trans by the peptide encoded by the alternatively 
spliced 5HT2C gene product RNA1 [28]. The potential diversity in signaling properties of the 
many heterodimer combinations that can be created forces us to consider a staggeringly complex 
network of functional regulation. Evolution has apparently seized upon the great functional 
diversity afforded by a 5HT2C editing-splicing-dimerization network and may employ the 
receptor in a variety tasks [27]. The fact that this system appears to be relatively well conserved 
from rodents to primates highlights the importance of this particular editing network for proper 
CNS function.        
The initial discovery of RNA editing at GluR2 AMPA receptor subunits painted a 
primarily developmental picture regarding the functional significance of editing. This is because 
ADAR transcript levels increase during the course of development and GluR2 transcripts 
appeared to be edited rarely early in development and essentially 100% of the time in adults. 
These findings led to the speculation that editing was a bimodal process where the proteins 
encoded by edited transcripts would be favored later in development as more ADAR enzyme is 
expressed. The discovery of characteristic intermediate editing at multiple sites on 5HT2C 
transcripts added complexity to this model because it implied that evolution had selected 
functions for both edited and non-edited proteins in adult animals. The conserved nature of 
editing at 5HT2C transcripts and others tells us that that a balanced expression of each 
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 functionally distinct isoform is required for normal physiology. This opened up the possibility 
that editing at some substrates could independently vary from cell to cell, individual to individual 
and within an individual over time. Several studies were initially launched to test the hypothesis 
that 5HT2C editing is altered in the brains of people with psychiatric disorders. Unfortunately, 
these early studies were under powered and suffered important technical limitations that 
prevented meaningful systematic characterization of 5HT2C editing.  
 The development of massively parallel sequencing technology opened the door for 
HTMTA, which provided the first opportunity to accurately assess editing profiles for several 
substrates in a large number of samples. The studies described here have allowed for the 
identification of signature editing patterns in different brain regions that are common across 
species. The editing profiles in humans described above indicate that, for many of the substrates 
analyzed, editing efficiency is maintained within specific ranges depending on anatomical 
context rather than simply developmental stage. This implies that the mechanisms regulating 
editing are specific to each substrate and dependent on factors other than overall ADAR 
expression level. Interestingly, significant deviations from these signature editing profiles were 
be observed in some individuals in the human cohort. The fact that these deviations were 
expressed in multiple brain regions of certain individuals implies that global mechanisms for 
regulating editing efficiency are at play. Attempts to identify similar deviations in primates were 
unsuccessful, potentially owing to the greater similarity in genetic backgrounds or the common 
environmental conditions (chow, medication, etc.) compared to the human population.  
Only a handful of human individuals had editing profiles that fell outside of a single 
standard deviation from the mean editing at most sites. This confirms results from other recent 
studies showing that editing does not vary much between individuals [139], while adding new 
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 evidence that editing profiles can deviate significantly in certain individuals as a result of yet 
unidentified factors. Importantly, these variations seem to play out on a global scale (in multiple 
brain regions) and in some cases in multiple substrates rather than only a single substrate in a 
discrete brain region. In these cases editing is presumably influenced by some up-stream 
effectors, genetic or environmental, which push editing profiles outside of the ‘normal’ 
characteristic range. This is the first work providing a comprehensive analysis of editing at 
multiple substrates in multiple brain regions in humans so included below is a detailed 
descriptive summary of editing at each respective transcript analyzed in these studies. 
Editing patterns in the human brain 
5HT2C editing in the human brain 
 5HT2C transcripts are thought to be edited by both ADAR enzymes in most tissues. The 
apparent lack of ADAR1 expression in choroid plexus [109] presumably accounts for the lack of 
editing at the A and B sites in this tissue. In these studies, we analyzed editing profiles in 
striatum, cortex, and hippocampus. Our results indicate that the mean extent of editing in the 
striatum and cortex is slightly higher than in the hippocampus (2-way ANOVA with Bonferroni 
post-test p ≤ 0.01 at each site with the exception of the E and D sites when comparing cortex to 
hippocampus). The high variability in editing observed at this transcript was largely driven by 
three individuals with patient IDs 1113, 1199, and 1556. These individuals had low levels of 
5HT2C editing in all three brain regions indicating global deficiency in editing at 5HT2C 
transcripts. A more detailed discussion about these three patients is included at the end of this 
chapter.  
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 GABRA3 editing in the human brain 
 The highest variability observed for any editing site in this study was the GABRA3 
editing site which results in a substitution of isoleucine for valine at residue 342 (I342V). 
GABRA3 editing is highest in the cortex where editing occurs approximately 75% of the time in 
most human samples and lower levels (~60%) editing is observed in the striatum and 
hippocampus. This substrate had the largest variability and a large number of individuals with 
values greater than one standard deviation from the mean in every brain region, indicating that 
editing at this site is highly dynamic across individuals as well as across tissues (Figure 26).    
GluR4 editing in the human brain 
 GluR4 transcripts are subject to alternative splicing to generate the functionally distinct 
“Flip” and “Flop” isoforms [140]. These splice isoforms are expressed in partially exclusive cell 
populations in each of the brain regions analyzed [141]. As a result of these studies, a 
characteristic pattern of GluR4 editing emerged whereby the Flop isoform is more likely to be 
edited than the Flip isoform. This pattern is expressed in all three tissue types and is most 
pronounced in the striatum where less than half of the Flip transcripts are edited and nearly all of 
the Flop isoforms are edited. This could reflect a direct effect of editing on splicing or simply a 
result of cell-type bias in editing efficiency and expression.  
mGluR4 editing in the human brain 
 The functional significance of editing at mGluR4 encoding transcripts has not been 
elucidated. This editing event predicts a glycine substitution for the genomically encoded 
arginine at amino acid 124 (R124G). This amino acid substitution occurs in the N-terminal 
extracellular domain where it has been proposed to be involved in receptor dimerization [142]. 
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 mGluR4 transcripts are infrequently edited in all tissues analyzed where the observed frequency 
of editing was typically ~10%. There was no clear indication that the editing pattern observed in 
one brain region predicted the extent of editing in others. Meaningful interpretation of the overall 
results is precluded by the limited current understanding of how this editing event affects 
mGluR4 function, as such, elucidating the functional impact of mGluR4 editing is a subject of 
ongoing work. 
CADPS editing in human brain 
 The CADPS transcript encodes a protein thought to be important for docking and Ca2+- 
activated secretion of dense core vesicles. The lowest levels of CADPS editing were observed in 
cortex tissue samples where the extent of editing was ~10-20%, while editing in the striatum and 
hippocampus was more extensive (Figure 25). Analysis of editing of tissue from Rhesus 
macaque confirms that this pattern is conserved in other primate species (Figure 25). There was 
no evidence that the site-specific editing of other ADAR substrates or editing in other brain 
region significantly correlated with CADPS editing. The functional role of CADPS editing is not 
understood and additional work to characterize the effects of this amino acid substitution will be 
required for meaningful interpretations about the physiological significance of these patterns.  
 
GluR2 editing in human brain 
 GluR-2 (GRIA2) editing, resulting in the substitution of glutamine 607 for arginine 
(Q607R), was the first A-to-I editing event to be characterized [12]. Editing of this transcript is 
low in the developing murine nervous system, but high by adulthood [133]. Studies in a variety 
of mammals have revealed a highly conserved nearly 100% efficiency of editing for this 
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 transcript in adults. In agreement these observations, we quantified GluR-2 editing to be in 
excess of 99% in most of the human tissue samples analyzed for these studies (Figure 25). 
Interestingly, one individual (patient ID #1199) expressed a marked deficiency in editing at all 
substrates in each brain region analyzed. This included GluR2, where only 84%-92% of GluR2 
transcripts were edited depending on the brain region analyzed. This patient was a 35 year old 
female diagnosed with PWS. Unfortunately, additional patient history for this individual was not 
available.   
Global editing deficiency in three human patients 
As previously mentioned, much of the variability in editing was driven by the observation 
that three patients had global deficiencies in editing at the transcripts analyzed in these studies; 
patients 1199, 1113, and 1556. Patients 1199 and 1556 were females (ages 35 and 41, 
respectively) who had been diagnosed with PWS although patient 1556’s diagnosis was 
subsequently refuted by molecular diagnostic techniques described in chapter III. Patient 1113 
was a 56 year old male “control” whom was reportedly a heavy smoker and died of 
complications related to a respiratory infection. Two of these individuals; 1199 and 1113, had 
editing levels more than one standard deviation below the mean for GluR4, GABRA3, and 
5HT2C transcripts in all three brain regions examined. Interestingly, patient 1556 had a similar 
pattern of editing deficiency in hippocampal and striatal tissue, but had normal editing (less than 
one standard deviation from the mean) for all other substrates (GluR2, GluR4, mGluR4, 
GABRA3 and CADPS) in the striatum. These results indicate that common genetic or 
physiological factors influence the editing of 5HT2C, GluR4, and GABRA3 transcripts across 
different brain regions. It also suggests that GluR2, mGluR4, and CADPS might be regulated 
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 differently, since normal editing patterns for these substrates were observed in each of these 
patients. 
Conclusions 
This dissertation provides a more complete framework for understanding the nature of A-
to-I editing. It is now clear that evolution has conserved mechanisms for maintaining precise 
context-specific expression profiles for certain edited transcripts in adult primates. Expression of 
different 5HT2C editing profiles appears to be relatively unaffected by acute treatment with 
antidepressant and antipsychotic drugs, or repeated stress exposure in mice, and variations in 
physical activity in primates. However, divergent patterns observed in some human individuals 
suggest that while editing often falls within characteristic ranges, it can vary widely under certain 
circumstances. The fact that evolution has conserved editing within specific ranges across 
species suggests that the differences in editing observed in some human individuals included in 
these studies are likely to have consequences for CNS function. It will be important to identify 
the neurological consequences of altered editing profiles by studying larger human cohorts with 
detailed psychiatric and neurological histories. These further studies in large human populations 
will also facilitate discovery of gene X environment interactions and factors driving certain 
“abnormal” RNA editing profiles. Identification of factors capable of influencing editing profiles 
will provide important insights about previously unappreciated gene expression feedback 
processes. Once identified and better understood, these mechanisms will be used for building 
more complete models of CNS function and potentially even exploited for therapeutic purposes.  
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